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Abstract 
Members of the protein kinase C (PKC) superfamily transduce a myriad of transmembrane 
signals initiated by the formation of sn-l ,2-diacylglycerol (DAG). As the primary 
physiological agonist for C] donlain containing PKC isoenzynles, DAG functions to regulate 
the spatial and temporal parameters of PKC activity. It is now recognized that cellular 
DAG levels can vary from minutes to hours and even days. These observations have 
suggested a division of PKC functions that correlate to the duration of the cellular DAG 
signal. In their classical role, cPKCs respond acutely to the short-lived (1-2 nlin) DAG 
generated at the plasma menlbrane by the phospholipase C-mediated turnover of 
phosphoinositides. In contrast, a nl0re persistent DAG signal can be produced through a 
variety of physiologic as well as pathologic mechanisms, and this DAG has also been 
proposed to regulate PKC activity. Currently, there are conflicting data on this issue and the 
specific subcellular localization of cPKC during prolonged DAG is unknown. To investigate 
the target of PKC during sustained activation, green fluorescent protein (GFP) technology 
was utilized to nl0nitor the subcellular traffic of various PKC isoenzymes in response to 
treatnlent with either DAG-Inimicking phorbol esters or DAG-generating agonists (e.g. 
platelet-derived growth factor). In response to a persistent elevation of DAG, cPKC 
isoenzynles, (X and BII, translocated to the plasma membrane and to a juxtanuclear location 
in a variety of cell lines examined. Characterization of this compartment revealed that it 
overlapped/co-localized with a rab II-positive subcompartment of recycling endosomes 
concentrated around the MTOC/centrosome. The cPKC compartment was distinguish from 
the rab II-positive con1partment by several features including a requirement for kinase and 
phospholipase D activity, an enrichment of lipid raft components, and the independence of 
microtubules and temperature for maintenance of the structure. Investigation into the 
significance of this compartlnent revealed that cPKC translocation coincided with the 
attendant sequestration of membrane recycling components. Given these distinctions, it 
was proposed that this novel cPKC-compartment be named the pericentrion in order to 
distinguish it from the rab 11 subcompartment of recycling endosomes. Subsequent analysis 
of a disease model wherein cPKC is nlaintained in a persistently active state, in this case 
chronic hyperglycemia associated with type I and type II diabetes, revealed a possible role 
for cPKC in the dysregulation of GLUT4 trafficking in response to insulin. These studies 
identify a novel site for cPKC translocation and function in response to a physiological and 
pathological elevation of DAG. 
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Chapter 1: General Introduction and Overview of Protein Kinase C (PKC) 
5 
1.1 Historical Significance 
In 1953, Hokin and Hokin reported that application of acetylcholine (ACh) to pigeon 
pancreatic tissue slices resulted in a rapid incorporation of radioactive :np-orthophosphate 
into membrane phosphoinositides (PIs) and phosphatidic acid (PA) (Hokin and Hokin, 1953). 
From these observations, they hypothesized that the effect of ACh was due to the rapid 
degradation and resynthesis (turnover) of membrane PI lipids (which involves the transient 
fonTIation of sn-l ,2-diacylglycerol~ DAG), and that this 'PI cycle' could be stimulated through 
the binding of the ACh agonist to it's cell surface receptor. Subsequent investigations revealed 
that a Jarge number of extracellular agonists could also induce a 'PI response' including 
other neurotransmitters, growth factors, and hormones. Remarkably, despite the mention 
ofDAG in the original PI cycle schema, the physiologic significance of the receptor-mediated 
elevation of DAG went unknown for close to three decades. 
In 1977, while studying the biochemical properties of partially purified nucleotide-
dependent protein kinases, Nishizuka and coworkers identified a novel nucleotide-
independent protein kinase activity they named protein kinase M (PKM) (Inoue et aI., 1977; 
Takai et aI., 1977). The ~M' denoted the relatively high concentrations of magnesium that 
were required for catalytic activity toward some artificial substrates. Two years later, this 
same group reported the landmark observation that PKM was in fact a constitutively active, 
proteolytic cleavage product of a larger proenzyme (PKC) that exhibited calcium, 
phosphatidylserine, and DAG-dependent sensitivity (Takai et aI., 1979a; Takai et aI., 1979c). 
Although there was an immediate recognition that this newly identified kinase may 
functionally couple to extracellular signals that pronl0te PI lipid hydrolysis and DAG 
generation, a mechanism for how a soluble protein such as PKC and a membrane lipid 
interacted was initially unclear. A mechanism was revealed three years later when PKC 
was identified as the long sought cellular receptor for tumor-promoting phorbol esters, and 
that phorbol esters, which structurally resemble DAG and partition into membranes, could 
induce a shift in subcellular localization or 'translocation' of soluble PKC from the cytosol 
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to the plasma membrane (Castagna et aI., 1982; Kraft and Anderson, 1983). The model of 
PKC translocation and activation that emerged from these observations has served as a 
paradigm for the study of lipid-dependent signal transduction for more than 20 years. 
1.2 Classification of the PK C Superfamily 
The mammalian PKC superfamily is a large group of serine/threonine kinases organized 
together on the basis of structural homology and cofactor requirements (table 1). To date, 
the PKC falnily consists of eleven isoenzymes divided up into three subfamilies: the classical 
PKCs (cPKC u, ~I, ~II, y), which are calcium-dependent and activated by DAG and Sll-1 ,2-
phosphatidylserine (PS); and two calcium-independent subfamilies; the novel PKCs (nPKC 
b, E,11,8) activated by DAG and PS, and the DAG/phorboI ester-insensitive atypical PKCs 
(aPKC 'AIL ,~), which are activated in vitro by phosphatidylinositiol-3,4,5-trisphosphate (PIP ), 
3 
phosphatidic acid (PA), and ceramide (Liyanage et aI., 1992; Mellor and Parker, 1998; 
Nishizuka, 1992) (Table]). Currently little is known regarding the lipid regulation of nPKC8 
and aPKC'Ah. In addition, there has been the recent assignment of a newly identified kinase, 
PKD or PKC~, to the nove] PKC subfamily but given that it contains a catalytic domain 
with homology to calmodulin kinase, a transmembrane sequence, a pleckstrin homology 
domain, no autoinhibitory pseudosubstrate, and weak phorbol ester sensitivity, this 
classification is open to debate (Johannes et a1., 1995; Johannes et aI., 1994). 
1.3 Structural Domains - Functional Organization 
Common to all PKC family members is a protease-sensitive hinge region that when cleaved 
generates two distinct fragments; a 45-49 kDa carboxy-terminus fragment that contains a 
constitutively active catalytic domain, and a 20 to 40 kDa amino-terminus regulatory domain. 
It was the carboxy-terminus, catalytic domain fragment (PKM) that Nishizuka and coworkers 
first purified from bovine cerebellum and subsequently identified as part of a larger 
proenzyme (PKC) (Inoue et aI., 1977; Takai et aI., 1977; Takai et aI., 1979a). Although the 
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catalytic domain is common to all PKCs, it is the regulatory domain, with its heterologous 
orientation and distribution of lipid binding ITIodules, that determines a subfamily's cofactor 
requirements (Table 1 and Fig. 1.1). 
1.3.1 Regulatory Domain. 
Protein sequence analysis of the all PKC family members has revealed the existence of four 
conserved donlains (CI-C4) and five variable regions (V 1-V5). The amino-ternlinus 
regulatory domain contains the cysteine-rich C 1 and C2 conserved domains and variable 
regions V 1-V3: 
A) The C 1 d()Jl1 a in . The C 1 domain is the site of DAG and phorbol ester binding (Ono 
et aI., 1989a). This domain is present in the classical and novel PKC isoenzymes as a 
tandenl repeat (CIa, Clb) of 50-51 amino acids with the sequence H-XI2C-X
2
C-XliI4C-
X2C-X-lH-X2C-X7C, where H is histidine and C is cysteine. It is the presence of the cysteine-
rich zinc fingers that determines a subfamily's responsiveness to the second messenger 
DAG and phorbol esters. In vitro studies suggest that there are two functional consequences 
ofDAGJphorbol ester binding to cPKC: 1) DAG binding increases the affinity of the enzyme 
for membrane lipids and calcium. This is achieved through an alteration of the physical 
properties of the C 1 lipid binding module itself. Binding of DAGJPMA to the C 1 domain 
places a hydrophobic cap on top of what is typically, in an unbound state, a hydrophilic 
surface area. The effect of this physical alteration is to create a hydrophobic surface that is 
more likely to interact with menlbranes (Newton, 200 1 ~ Zhang et aI., 1995); 2) DAG binding 
leads to an increase in the kinase activity of the enzyme. Maximal activation of cPKC 
occurs when DAG is bound in the presence of calciulll and phosphatidylserine. Using a 
mixed micellar kinase assay, it has been demonstrated that DAG can bind and activate PKC 
on a 1: I molar ratio in the presence of less than 10 but more than 4 phosphatidylserine 
molecules (Hannun et a1., 1986; Hannun, 1985). 
The binding of DAG to the C 1 domain of cPKC isoenzymes is highly stereospecific and 
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there is an absolute requirement for 51n-1 ,2-DAG; the sn-l ,3- and 5n-2,3- configurations are 
inactive. Within the DAG structure, it is the oxygen esters of the fatty acyl chains and 511-3 
hydroxyl group on the glycerol backbone that are essential for DAG activation of PKC 
(Cabot and laken, 1984; Ganong et aI., 1986; Hannun, 1985). In contrast, the atypical PKC 
isoenzymes, which contain an abbreviated C 1 domain with only a single cysteine-rich zinc 
finger (most similar to the C I b of the cPKCs), are insensitive to DAG and phorbol esters 
(ana et aI., 1989b; Ways et aI., 1992). In vitro studies suggest that the aPKC are activated 
by PA and PIP 3 but presently there is little in vivo data to support this (Limatola et al., 1994; 
Nakanishi et aI., 1993). 
B) The C2 Do]nail1. The C2 domain of the classical PKC isoenzymes binds anionic 
phospholipids in a calcium-dependent manner (Shao et aI., 1996). The C2 domain is located 
immediately following the C 1 domain in cPKC's, but precedes the C 1 and is truncated in 
the nPKC's (Fig. 1.]). Biochemical and crystallographic analyses have revealed that the 
C2 domain contains a calcium-binding pocket that is formed by aspartate residues flanking 
the C2 domain at the amino and carboxy ends. An intracellular elevation in calcium leads 
to the coordination of two calcium ions by the flanking aspartate residues and this drives a 
conformational change that permits the anionic phospholipid head group (e.g. 
phosphatidylserine) to enter and bind (Grobler et aI., 1996). It is the calcium-coordinating 
aspartate residues that are missing from the nPKC isoenzymes and their absence is thought 
to be responsible for this subfamily's lack of calcium dependence (Newton, 1995). The 
atypical PKCs do not contain a C2 domain and there is no evidence for calcium-dependent 
activation of these isoenzymes. 
C) Pseudo51ub5trate Site. Immediately amino-terminal to the C 1 domains of all PKC 
isoenzymes (except PKC~) is the autoinhibitory pseudo substrate site (Fig. 1.1). The 
pseudosubstrate is an autoinhibitory module that contains a sequence of basic amino acid 
residues that mimics a PKC substrate but with an alanine in place of the predicted serine/ 
threonine (House and Kemp, 1987). A model for PKC autoinhibition proposes that in an 
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unstimulated state, the pseudosubstrate domain folds back into the catalytic domain and 
blocks substrate binding through physical occupation. The subsequent binding of an 
activating lipid second messenger, such as DAG, will then induce a conformational change 
that causes the displacement of the pseudosubstrate from the active site and the binding a 
specific substrate. This model is supported with data from molecular studies in which 
deletion of the pseudosubstrate domain results in an enzyme that exhibits lipid-independent 
kinase activity (Orr et aI., 1992). 
D) The V3 region. Also known as the hinge region, the V3 region contains the calcium-
dependent (calpain I or II) protease-sensitive cleavage site that functionally separates PKC 
into regulatory and catalytic domains (Kishimoto et aI., 1989; Takai et aI., 1979b). In addition, 
there is emerging evidence that the hinge region may contain non-traditional nuclear 
localization signals (bipartite NLS) that target both PKCa and Alt to the nucleus under 
certain conditions (Malviya and Block, 1992). 
1.3.2 The Catalytic Domain. 
The catalytic domain consists of the C3 and C4 conserved subdomains, and the variable 
regions V 4-VS. 
A) The C3 d0111aill. The C3 domain contains a putative ATP-binding site found in many 
other protein kinase enzymes (Kemp and Pearson, 1990). It consists of the conserved motif 
Gly-X-Gly-X-X-Gly-XI~-Lys. Site-directed mutagenesis of the conserved lysine residue to 
an arginine results in a fuJ] length enzyme that is unable to bind ATP and therefore lacks 
kinase activity. The use of PKC kinase-defective (K-R) mutants, which appear to function 
as dominant negative genes, has proven invaluable to cell biologists studying the cellular 
functions ofPKC. Interestingly, the C3 domain of the aPKC isoenzymes is slightly different 
than other PKC family members due to the replacement of the third glycine with an alanine. 
The functional significance of this difference is presently unknown. 
B) The C4 domain. The C4 domain is the most proximal of all conserved PKC domains 
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(Fig. 1.1). This region contains the substrate binding site and phosphotransfer site (Nishizuka, 
1988b). 
C) The V5 region is a key site for cellular regulation. The V5 region is approximately 
50 amino acid long and located at the carboxy terminus end of all PKCs (Fig. 1.1). This 
region, which was identified through sequence alignment of all the cPKCs isoenzymes, was 
initially assumed to be unimportant for activity. Identification of alternative splice products 
of the cPKCB gene, which leads to the production of two gene products that are identical 
except for the V 5 region, suggested that this region n1ay confer specific properties and 
functions. It is now recognized that conserved residues contained within the V 5 region are 
required for a variety of cellular regulatory functions (Blobe et aI., 1996a; Kiley and Parker, 
1995~ Mellor and Parker, 1998; Stebbins, 200 I) (see below). 
1.4 Cellular Regulation of PKC 
Biological activity of PKC is dependent upon the ability of individual isoenzYlnes to gain 
access to activating lipid signals and compartment-restricted substrates. As it is currently 
understood, the cellular regulation of PKC involves a con1plex interplay of acute structural 
modifications (trans- and cis-phosphorylation events), and lipid-protein and protein-protein 
interactions that combine to determine the spatial parameters of PKC activity (Kiley et a1., 
1995; Mochly-Rosen and Gordon, 1998; Nishizuka, 1992). 
1.4.1 Regulation of PKC through phosphorylation The allosteric modulation of 
signaling enzymes through the addition and removal of phosphate groups has emerged as a 
major mechanism in which to control intrinsic enzymatic activity (Wera and Hemmings, 
1995). Recent data suggest that the activation state of PKC is highly dependent upon 
exogenous and endogenous phosphorylation events at three conserved serine/threonine 
residues found in the carboxy terminus half of the protein (Keranen et al., 1995). In the case 
of cPKCBII, newly synthesized enzyme is phosphorylated by phosphoinositide-dependent-
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kinase-l (PDK-l) at a conserved threonine residue (TSOO) within the activation loop of the 
catalytic domain (Fig. 1.2). The phosphorylation of the TSOO is the rate-limiting step in the 
maturation of PKC into a fully active enzyme. Mutational analysis of this site has revealed 
that the inability to phosphorylate TSOO can lead to an unstable and dephosphorylated enzyme 
devoid of kinase activity (Orr and Newton, 1994). Phosphorylation at TSOO is necessary for 
autophosphorylation at the more proximal threonine 641 (T641) and serine 660 (S660). In 
turn, autophosphorylation of T641 is the key regulatory switch that locks PKC into a 
catalytically competent conformation and without it PKC is insensitive to activating lipid 
signals. Once autophosphorylation has occurred at T641, the phosphorylation status of 
TSOO becomes less critical to the overall activity of the enzynle (Keranen et aI., 1995). 
Whereas T641 is required for activity, phosphorylation at S660 appears to nl0dulate protein 
stability, and interactions with protein substrates and cofactors (Mellor and Parker, 1998; 
Newton, 2001). Previous data from our laboratory have demonstrated the requirement of 
phosphorylation at S660 for regulation of subcellular localization. Using a GFP-tagged 
serine to alanine mutant of cPKC~II, we found that phosphorylation at S660 is necessary 
for the reverse translocation of cPKC back to the cytosol following recruitnlent to the plasma 
membrane with DAG-generating agonists such as angiotensin II (Feng et aI., 2000). In 
support of these data, we also observed an increase in phosphorylation at S660 following 
phorbol ester treatment suggesting that the phosphorylation of S660 may be subjected to 
dynamic regulation in response to agonists (unpublished results). 
1.4.2 Lipid regulation of cPKC isoenzymes. In cells, DAG produced in the cell 
membrane can regulate the subcellular localization of DAG/PMA sensitive cPKC and nPKC 
isoenzymes. This form of PKC regulation was first described for agonists coupled to PI-
specific phospholipases but any elevation of intracellular DAG may represent a potential 
source of lipid regulation for C 1 domain containing PKC isoenzymes. 
A) DAG derived from PI lipid hydrolysis: The classical model of PKC activation. 
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The PI-PLC falnily, which acts on PI lipids and especially phosphatidylinositol-4,5-
bisphosphate (PIP 2)' consists of eleven isoenzymes that can be arranged into four subfamihes 
(~, 0, f, y) on the basis of structural homology and regulatory mechanisms. Members of the 
PLC family have been implicated in the cellular response of more than 100 different cell 
surface receptors. Activation of PI-PLC occurs through several receptor-directed mechanisms 
including heterotrimeric G-proteins, receptor tyrosine kinases and non-receptor tyrosine 
kinases (Rhee, 2001). In the case of the PLC-~ subfamily, binding of an extracellular agonist 
to a G-protein-coupled receptor leads to the dissociation of heterotrimeric G-proteins into 
separate G a and G~y subunits. Both G a and G~y have been shown to activate PLC-~ 
q q 
isoenzymes. On the other hand, growth factor binding to receptor tyrosine kinases stimulates 
intrinsic kinase activity and the autophosphorylation of tyrosine residues on the cytoplasnlic 
ends of the receptor. These phosphorylated residues serve as docking sites for nlany SH2 
domain-containing proteins including PLC-y. 
Activated PI-PLC hydrolyzes the phosphodiester bond of the inositol phosphate head 
group of PIP 2 to liberate the second messengers, inositol-1 ,4,5-trisphosphate (IP) and DAG 
(Fig. 1.3). Soluble IP
3 
diffuses into the cytoplasm and binds receptors on the endoplasmic 
reticulum, leading to the release of internal calcium stores and an elevation in free intracellular 
calcium. In addition to activation of calciUm/calmodulin-regulated targets, the increase in 
intracellular calcium acts in concert with membrane-bound DAG to shift the equilibrium of 
inactive, soluble PKC from the cytosol to the inner face of the plasflla membrane where it 
can bind DAG and acidic phospholipids such as phosphatidylserine. The binding of DAG 
at the plasma membrane leads to a conformational change that displaces the autoinhibitory 
pseudosubstrate from the active site. 
DAG formed from the hydrolysis of PI lipids first appears in the membrane within seconds 
of receptor occupancy, but levels drop rapidly thereafter and basal levels are restored within 
1-2 minutes (Cook et a1., 1990; Hughes et aI., 1984; Nishizuka, 1992; Wright et a1., 1988). 
The duration of the DAG signal is determined by the availability of PIP
2 
in the cell, which 
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typically represents less than 1 % of the Dlass of aJ] phospholipids, and by rapid metabolic 
clearance of DAG by DAG kinases and hydrolases. The presence of PKC at the plasma 
membrane closely paraJlels cellular DAG levels. 
B) DAG derived from PC hydrolysis. Many of the extracellular ligands that stimulate 
PI-PLC will also activate other lipases. This was first recognized in 1985 when it was noted 
that the agonist-induced accumulation of DAG in hepatocytes did not correlate with the 
formation of IP~ (Bocckino et aI., 1985). When the DAG mass was analyzed it was found 
that stimulation of cells resulted in two peaks of DAG accumulation. The first peak, which 
appeared rapidly after agonist stimulation and lasted 1-2 minutes, was attributed to the 
actions of PI-specific PLC. This early peak was then followed by a second, more sustained 
elevation of DAG that reached a maxilnal peak within 5-10 minutes and remained sustained 
over basal levels for several hours. Molecular analysis of the fatty acid composition of this 
sustained peak of DAG revealed that it contained relatively high amounts of saturated and 
mono-unsaturated (e.g. palmitic, oleic, and linoleic) acyl chains at both the sl1-1 and sl1-2 
positions. The chemical composition of these fatty acyl chains was indicative that the 
sustained phase of DAG was derived from the hydrolysis of PC (Pettitt et aI., 1997; Pettitt 
and Wakelam, 1993). 
PC-spec~fic phospholipase D (PC-PLD). Although long appreciated to exist in plants, 
the first direct evidence of a receptor-regulated mammalian PC-specific phospholipase D 
(PC-PLD) activity was reported in differentiated HL-60 cells stimulated with N-formyl-
Met-Leu-Phe (fMLP) (Pai et aI., 1988a; Pai et aI., 1988b). There is now ample biochemical 
data to support a role for an agonist-induced PC-PLD activity in the generation of DAG 
from PC. The mammalian PC-PLD family consists of two genes, PLDI and PLD2, as well 
as several gene products produced through alternative splicing events. PC-PLD 1 can be 
stimulated by calcium-dependent PKCa and ~II, and the small GTPases Rho and ARF. The 
PC-PLD2 isoenzyme, which is maintained with a relatively high basal activity, exhibits 
only a modest increase in activity in responses to ARF and PKC, and requires PIP 2 as a lipid 
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cofactor. Once activated, PC-PLD cleaves the phosphodiester bond of PC to generate PA 
and free choline. Although it has been demonstrated in vitro that PA can modulate the 
activity of several proteins, this remains to be conclusively established in vivo. In most 
cells, PA generated from the hydrolysis of PC is rapidly nletabolized to DAG through the 
actions of PA phosphohydrolase (PAP) which appears to be variably active in different 
cells, thus accounting for variable accumulation of PA versus DAG from the action of PLD 
(Mullmann et aI., 1990). 
The critical question arises as to whether DAG derived from PC hydrolysis can activate 
PKC analogous to PI-derived DAG. Presently, this is a hotly debated issue and data exist 
supporting both contentions. Numerous in vitro studies have indicated that polyunsaturated 
DAG or DAGs derived from PI lipids can effectively activate PKC but that saturated and 
monounsaturated DAG species were less effective (Marignani et aI., 1996; Martin et aI., 
1990; Schachter et aI., 1996). These conclusions are not definitive for two main reasons: I) 
there is an inherent difficulty in presenting lipids with structural variations in their acyl 
chains with similar consistency iii vitro. Thus, differences in saturated DAG and 
polyunsaturated DAG may not be due to true affinity differences but actually due to 
inconsistencies in the incorporation of these lipids into vesicles or micelles; 2) the cellular 
regulation of PKC is much more cOlllpJex than can be reproduced in an in vitro environment. 
Cellular activity of PKC is influenced by a large variety of cofactors and spatially defined 
parameters that would be difficult to minlic in vitro. It is quite possible that a localized 
concentration of saturated DAGs, along with certain cofactors (e.g. PS), may be sufficient 
to overcome the lower affinities measured relative to polyunsaturated DAGs in vitro. In 
order to draw accurate conclusions of events at the ce]]ular level, a greater understanding is 
needed of the bioactivity of individual molecular species of DAG and the subcellular 
compal1ments in which they arise/reside. 
The ability to examine the relationship of PKC and PC-derived DAGs in vivo is further 
complicated by the lack of a well-defined model system wherein a single agonist wi]] activate 
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one phospholipase and not another (PI-PLC versus PC-PLD). Agonists that are typically 
utilized include platelet -derived growth factor (PDGF), bombesin, and carbachol. The 
disadvantage of each of these agonists is that they produce a biphasic elevation of DAG 
through simultaneous activation of PI-PLC and PC-PLD. Similar to the in vitro studies 
with saturated DAGs and PKC, there are also conflicting data from these studies. Whereas 
some groups have found no activation (as measured with translocation to a particulate 
fraction) of PKC with PC-PLD activation (Leach et aI., 1991), others have found some 
persistent membrane association (Ha and Exton, 1993). 
One system that has been utilized to address this issue is the porcine aortic endothelial 
(PAE) cells where stimulation with lyso-phosphatidic acid (LPA) induces the activation of 
PLD without a concomitant stimulation of PI-PLC (Pettitt et aI., 1997). Data from this 
model suggested that saturated-monounsaturated DAGs were unable to activate PKC; 
however, these results must be interpreted with some caution since there was significant 
basal membrane translocation ofPKC in the absence ofLPA stimulation which was possibly 
due to a large amount of polyunsaturated DAGs that were evident in these cells. 
At present the question of whether DAG derived from PC can activate PKC is still open, 
but this issue may be particularly amendable to emerging technologies such as mouse embryo 
fibroblasts (MEF's) that can be generated devoid of complicating lipases, and RNA 
Interference (RNAi) technology. 
PC-specific phospholipase C (PC-PLC). There are reports that DAG can also be derived 
from PC through the actions of a PC-PLC which would generate DAG directly as well as 
choline phosphate (Sheikhnejad and Srivastava, 1986; Wolf and Gross, 1985). Several 
studies have suggested the presence of a PC-specific PLC activity which was stimulated by 
TNF-a and cross-linking antibodies to the B-cell receptor. Unfortunately, progress in this 
area has suffered from a lack of purified PC-PLC and from lack of molecular cloning of 
such an enzyme from mammals. Conclusions from these studies have been further 
complicated by the use of the pharmacological inhibitor D609 which was discovered to 
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inhibit PC-PLC from bacterial species in vitro, and used to implicate the existence of a 
mammalian PC-PLC. Unfortunately, D609 has never been shown to inhibit a n1ammalian 
PC-PLC. On the other hand, D609 has been shown to inhibit mammalian-PC:ceramide 
phosphocholine transferase (sphingomyelin synthase~ SMS) (Luberto and Hannun, 1998) 
and PC-PLD (Kiss and Tomono, 1995) at similar concentrations used to inhibit bacterial 
PC-PLC. Given the underdetermined specificity of the D609 inhibitor, the existence of a 
genuine PC-PLC is unclear, and the possibility exists that the activity characterized in these 
studies may have been misidentified. 
DAG produced during sphingolnyelin synthesis. Evidence of a sphingomyelin cycle 
(SM cycle) was first described in 1989 when it was reported that the application of 1 a,25-
dihydroxyvitaminD~ could stimulate the hydrolysis of SM with the subsequent generation 
of choline-phosphate and the lipid second messenger, ceramide (Hannun, 1994; Okazaki et 
aI., 1989). During the resynthesis phase of the SM cycle, SM synthase utilizes cerami de 
and PC to generate SM and DAG. A possible physiological role for DAG derived from SM 
synthesis has been proposed for the regulation of NF-KB (Luberto et aI., 2000). Sin1ilar to 
PC-PLC, a detailed molecular understanding of this enzyn1e and its lipid products awaits 
molecular cloning. 
1.4.3 Regulation of PKC through membrane translocation. The groundbreaking 
discovery by Nishizuka and colleagues that unsaturated DAG was the agonist for PKC did 
not yield an immediate understanding of how DAG and PKC interacted (Takai et aI., 1979a; 
Takai et aI., 1979c). A subsequent report by Castagna et al. also from Nishizukas' group, 
identified PKC as the celJular receptor for tumor promoting phorbol esters, but provided 
only slight clues as to the mechanism (Castagna et aI., 1982). At that time, it was known 
that phorbol esters mediated their cellular responses by primarily acting on receptors at the 
ceJ] membrane. Thus, it was inferred that the target of PMA was PKC at the plasma 
membrane. In 1983, Kraft and Anderson demonstrated that treatment of parietal yolk sac 
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(PYS) cells with PMA could induced a shift in the subcellular distribution of PKC from the 
cytosol to the particulate or membrane fraction (Kraft and Anderson, 1983). These data 
provided a mechanism for the interaction of PKC and DAGIPMA, whereby soluble PKC 
responds to the presence of DAG or PMA in the membrane by "translocating" to the 
membrane surface from the cytosol. These observations served to establish the translocation 
of PKC to the membrane fraction as the conceptual and biochemical hallmark of PKC 
activation that stilJ stands today. 
Just how PKC interacts with DAG and other lipids at the membrane has been the subject 
of intense investigation. Using a novel mixed micellar method to investigate the specificity 
and stoichiometry of PKC-lipid interactions, Hannun et a1. reported that full activation of 
PKC occurred when a single molecule of DAG was presented in the context of several 
molecules of phosphatidylserine (PS) (Hannun, 1985). Further, with this approach they 
demonstrated the remarkable specificity for the interaction of PKC with both DAG and PS 
(Hannun et aI., 1986). 
The model that arose out of these in vitro findings was that four molecules of PS bind 
Ca2+ at the membrane surface and that this creates a PS-Ca2+ complex that initiates the 
binding of inactive PKC to the membrane. The subsequent interaction of DAG with PKC 
bound at the membrane to the PS-Ca2+ complex leads to the full activation of the PKC 
activity (Hannun et aI., 1986). This model fits very well with the mechanics of PI lipid 
turnover and generation of DAG which has been shown to be preceded by an intracellular 
elevation of Ca2+ 
For more than 15 years, the plasma membrane was conceptualized as the prinlary target 
for PKC translocation without the confirmation. Although the use of subcellular fractionation 
provides information regarding whether PKC has moved from a soluble location to a 
membrane (particulate) fraction, this approach has limitations that include the inability to 
resolve specific compartments, and the possibility of artifactual (e.g. false negative) results 
due to ex vivo effects. This changed with the development of green fluorescent protein 
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(Cubitt et aI., 1995). Beginning in the mid 1990's, several groups took advantage of GFP to 
tagged PKC so as to monitor PKC localization in live ceJ]s following agonist stinlulation. 
SpecificaJ]y, their approach demonstrated and confirmed that PKC does in fact translocate 
to the plasma membrane, and that this occurs in a highly dynamic manner involving multiple 
lipid binding domains and kinase activity (Feng et aI., 1998; Oancea and Meyer, 1998; 
Sakai et aI., 1997). Future investigation of PKC with a similar approach has the potential to 
take our understanding of the celJular regulation of PKC to the next level. 
1.4.4 Regulation of PKC subcellular localization through protein-protein 
interactions. Although there is little debate that lipid-dependent translocation/activation 
of PKC at the plasma membrane represents a fundamental form of PKC regulation, there 
have been subsequent discoveries that suggest that this model may not be applicable to all 
forms of PKC regulation. In particular, identification, molecular cloning, and sequence 
analysis has revealed variations in the complement and composition of conserved domains 
(C 1 and C2) found distributed throughout the PKC family members (Coussens et aI., 1986; 
Knopf et a1., 1986; Ono et aI., 1986b; Parker et aI., 1986). The implications of these findings 
is that different forms of regulation may exist (Nishizuka, 1988a). Further, biochemical 
studies have revealed that there is little in vitro substrate discrimination anl0ngst different 
PKC isoenzymes (Kazanietz et aI., 1993). This lack of substrate selectivity in vitro suggested 
that mechanisms must exist within cells that would function to coupled PKC to specific 
substrates. Evidence in support of this proposal has come from immunofluorescence studies 
which revealed differential subcellular localization of PKC isoenzymes (Goodnight et al., 
1995). In addition to the cytosol and plasma membrane, PKC has now been localized to the 
golgi (Goodnight et aI., 1995), cytoskeleton (Blobe et aI., 1996a; Ito et a1., 1989; Mochly-
Rosen et aI., 1990), mitochondria (Majumder et aI., 2000), nuclear envelope (Hocevar and 
Fields, 1991; Leach et aI., 1989), and nucleus interior (Beckmann et aI., 1994; Neri et a1., 
1994). These findings have been used to support the hypothesis that substrate selectivity 
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i.e. isoenzyme-specific functions of PKC at the cellular level may be mediated by targeting 
PKC to distinct regions of local substrates, and that this targeting can be carried out be lipid 
second messengers, such as DAG, as well as more recently, through PKC binding proteins. 
In the early and mid] 990's several groups undertook an effort to identify PKC binding 
proteins. From these studies, several classes of proteins were identified including STICKS 
or substrates interacting with C-kinase, RICKS or receptors for inactive C-kinase, RACKs 
or receptors for activated C-kinase, PICKs or proteins that interact with C-kinase, and 
scaffolding proteins including] 4-3-3 and AKAP (Jaken and Parker, 2000; Mochly-Rosen 
et aI., 199 I; Staudinger et aI., ] 995). As it turns out, many of these proteins are nonspecific 
and bind multiple PKCs (scaffolding proteins e.g. AKAP), but others have been reported to 
bind to specific PKC isoenzymes (RACK 1 to cPKCBII). Moreover, it has been reported 
that PKC binding proteins can recognize a variety of PKC states including an 
unphosphorylated-inactive forn1, a phosphorylated-inactive, or a phosphorylated-active form 
(Jaken and Parker, 2000). Importantly, many of these protein-protein interactions are lipid 
dependent and most of these PKC binding proteins are themselves lipid binding proteins. 
Nonetheless, disruption of these interactions leads to the mislocalization of PKC and the 
disruption of PKC signaling, suggesting a significant contribution of these protein-protein 
interactions in PKC regulation (Jaken and Parker, 2000). 
1.5 Cellular Functions of PK C 
Activated PKC catalyzes the transfer of a terminal y phosphate of ATP to serine and threonine 
residues on protein components of signaling cascades. Many of the biological functions 
proposed for PKC have been derived from: 1) cellular responses elicited by agonists coupled 
to the generation of DAG and which were sensitive to PKC inhibitors; 2) application of 
cell-permeable DAG analogues or phorbol esters; 3) overexpression studies; 4) in vitro 
kinase assays with recombinant or immunoprecipitated protein; and 5) knockout or transgenic 
mouse models. 
20 
The general picture that has emerged from these studies suggests that there is enormous 
heterogeneity in the cellular functions of PKC. Currently, at least 110 PKC substrates have 
been identified, and these span the range of tissue types and physiological functions. Some 
examples of PKC substrates include neuromodulin, MARCKS protein, several of the classes 
of G-protein coupled receptors (e.g. cholinergic, catecholinergic, tryptaminergic), growth 
factor receptors (e.g. EGF), metabolic enzymes (e.g. glycogen synthase), signaling enzymes 
(e.g. MAPK), cytoskeletal proteins (e.g. adducin), nuclear proteins (e.g. lamin B), and the 
proto-oncogene (e.g. pp60c-src) (Dempsey et aI., 2000b). The breadth of these putative 
substrates is indicative of the evolutionary advantage of PKC activity that can be found 
conserved throughout biology. 
1.6 Acute versus long term PKC activity. 
It had been proposed by Nishizuka and colleagues, and more recently by Blobe et a1. that 
the cellular functions of PKC can be divided into two general types based upon the persistence 
of the DAG signal: 1) those cellular functions that require an acute activation ofPKC (occurs 
on the order of nlinutes) and primarily target lipids signals generated at the cell membrane~ 
and 2) functions that require long term PKC activity (hours-days) (Blobe et aI., 1996b; 
Nishizuka, 1986~ N ishizuka, 1995). 
1.6.1 Role of PKC as mediator of acute signal transduction events. Translocation 
and activation of PKC at the plasma membrane is a key event in PKC-dependent signal 
transduction. This classical role of PKC was first described for the release of serotonin 
from platelets during platelet activation. A similar mechanism of activation has since been 
demonstrated for a large number of other cellular functions including neurotransmitter release, 
secretion, vascular snl00th muscle contraction and relaxation, lipogenesis, and 
glycogenolysis. All these events have in common that they involve a transient (1-2 min) 
elevation of lipid second messengers and the reversible translocation of cPKCs to the plasma 
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membrane. 
1.6.2 Role of sustained PKC activity in cell physiology and disease states. Sustained 
PKC activity is required for normal physiological functions such as cell differentiation, 
mitogenesis, and gene expression. Persistent PKC activity has also been implicated in a 
variety of diseases and disease models. 
A) Role of DAG-PKC in tumor progression and cancer. A major role for DAG in celJ 
growth and tUITIorigenesis was established when it was discovered that tumor-promoting 
phorbol esters could functiona]Jy and structuraJJy recapitulate DAG generated at the plasma 
membrane (Castagna et aI., 1982; Niedel et a1., ] 983; Yamanishi et aI., 1983). These 
observations inlplicated a direct role for DAG and its primary cellular target, PKC, in the 
cellular changes that occur during tumor progression. Further, a role for protein kinase-
mediated phosphorylation in tumor promotion is also supported by the observation that 
another tumor promoter, okadaic acid, is an inhibitor of protein phosphatases. 
Extensive investigation into the nlechanisnl of tumor-promotion by phorboI esters suggest 
that they induce their effects through a wide variety of biochemical changes including 
increases in reactive oxidative stress, secretion of proteases and co]Jagenases, alteration of 
gene expression, protein phosphorylation, and cytoskeletal changes. In nlany cases these 
cellular alterations lead to uncontro]Jed ce]J proliferation associated with tumorigenesis but 
in other cases they may result in celJ differentiation or even ceJ] death depending upon cell 
type (and complement of DAG/phorbol ester-sensitive PKC isoforms expressed). PKC has 
been directly implicated through overexpression studies which found PKCa, ~II, E, and ~ 
all associated with either tumor promotion, increased cell survival or suppression of apoptosis. 
In contrast, nPKCb exhibited pro-apoptotic functions (Blobe et aI., 1994~ Denlpsey et aI., 
2000a). 
A role for sustained DAG is supported with molecular studies that have correlated the 
overexpression of the small GTPase oncogenes ras or sis with the elevation ofDAG and the 
22 
transformed state of the cells (Fleischman et aI., 1986; Preiss et aI., 1986; Wolfman and 
Macara, 1987). The increase in DAG was concluded to be derived from an enhanced rate of 
phospholipid turnover (phospholipase-mediated) and not a de novo synthesis of 
glycerophospholipids (Fleischman et aI., 1986). These data implicate a role for the abnormal 
activity of glycerophospholipid metabolizing enzymes in the progression toward the 
transformed phenotype. 
B) Role of DAG-PKC in diabetes. Chronic hyperglycemia is a major initiator of the 
pathological complications associated with type 1 and type 2 diabetes (Sheetz and King, 
2002). Many of the effects of hyperglycemia are mediated through a sustained elevation of 
DAG and the activation of DAG/PMA-sensitive PKC isoenzYlnes (Way et aI., 2001). 
Sustained elevations of DAG and PKC activity have been detected in the endothelial tissues 
of the heart, aorta, retina, brain, nerves, and kidney of diabetic anin1al nlodels and diabetic 
patients. Indeed there are clinical trials underway evaluating the efficacy of cPKC(3 specific 
inhibitors (e.g. LY333531) in blocking the complications of diabetic nephropathy and 
neuropathy. The hyperglycenlia-induced elevation ofDAG has been attributed to an enhanced 
flux through the glycolytic pathway and the de novo biosynthesis of glycerolipids but data 
supporting these contentions is incomplete. At present, there is a great need to identify the 
mechanism(s) of hyperglycemia-induced DAG elevation for future therapeutic developnlent. 
C) Role of DAG-PKC in neurological diseases Abnornlal enzYlnatic activities of PI-
PLC, PC-PLD, and PLA
2 
have been detected in a variety of neurological disease states 
including Alzheimer's disease, Huntington disease, schizophrenia, and in some 
neurodegenerative disease models. Although the key neurochenlical mechanisms underlying 
these enzymatic abnormalities are unknown, it is predictable that DAG levels, and 
subsequently PKC activity, will be abnormal as a result. Further, PKC may also have a role 
in the control of gliaJ ceJl regulation. The characteristic molecular feature of nlany prilnary 
tumors of the eNS is an overexpression or hyperactivity of select PKC isoenzymes (Bredel 
and Pollack., 1997; Sharif and Sharif, 1999). 
23 
D) Role of DAG-PKC in cardiac disease. The link between DAG-PKC and cardiac 
disease was established through the analysis of several mouse models of cardiac hypertrophy. 
Utilizing a transgenic mouse model, Lefkowitz and colleagues noted that the constitutive 
expression of the a, -adrenergic receptor resulted in a cardiac hypertrophy phenotype and 
an accumulation of DAG which they attributed to the prolonged and aberrant activation of 
receptor-coupled phospholipases (Milano et aI., 1994). DAG signaling has also been 
implicated with data from transgenic mice that expressed a constitutively active cPKC~II. 
This model exhibited a hypertrophic phenotype similar to the aI-adrenergic mouse model 
which could be alleviated with PKC inhibitors (Wakasaki et aI., 1997). 
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1.7 Rationale/preliminary data. 
Unlike the classical model of PKC activation where the primary site of PKC translocation 
and activity is the plasma membrane, little is known about the subcellular localization of 
PKC during more sustained activation. Data that are available come from studies that have 
primarily assessed the activation state of PKC and not the specific subcellular target of 
translocation. Most of these studies employed a generalized biochemical approach wherein 
the cellular movement or translocation (i.e. activation) of PKC was nlonitored by subcellular 
fractionation and immunoblotting for PKC. More recently, the use of confocal microscopy 
and GFP technology has provided a complementary approach to fractionation studies but to 
date they have been used primarily for the examination of the acute activation of PKC 
activation/translocation. Very little microscopic information is available addressing the 
cellular behavior of PKC under physiological and pathological conditions of sustained 
activation. 
Using the PDGF~ receptor (PDGF~-R) as an endogenous source of sustained DAG, we 
investigated the subcellular localization of GFP-tagged cPKC isoenzylnes in live cells with 
confocal imaging. Overexpression of the PDGFB receptor in the presence of serum led to a 
modest translocation of GFP-cPKCa to the plasma membrane. In addition, translocation to 
a secondary, juxtanuclear location that was also evident. Importantly, this translocation 
was not observed in the absence of serum, and juxtanuclear translocation could be restored 
with the addition of PDGF-BB to the serum-free culture media. To confirm that PC-PLD 
was activated through PDGF-BB stimulation, a transphosphatidylation assay was perfornled 
in paraUel with the microscopic studies. PC-PLD activation occurred in the presence of 
PDGF and with serum. Thus, confocal imaging and the use of the PDGF receptor coupled 
to PC-PLO alJowed the visualization of an membrane compartment distinct from the plasma 
membrane that serves as a target for PKC translocation during sustained activation. 
This juxtanuclear accumulation of PKC stimulated with PDGF-BB was similar to a novel 
site of translocation which we have recently identified using DAG-mimicking phorbol esters 
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Thus, long term (I hr) PMA can recapitulated the juxtanuclear compartment that was observed 
with PDGF stimulation. This suggested that PMA could be used to probe the properties and 
mechanism of PKC translocation to this novel compartment. 
What follows are the data that describe the identification, characterization, and function 
of this novel site of cPKC translocation during long term activation. Moreover, cPKC 
translocation is investigated and discussed within the context of glucose transport in the 
diabetic cell model. 
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Mammalian PKC Superfamily 
subtype Mw(KDa) Activators Tissue Ex(!ression 
grp A, classical 
a 76.8 PS, Ca, DG, FFA, LPC ubiquitous 
~I 76.8 PS, Ca, DG, FFA, LPC various 
76.8 PS, Ca, DG, FFA, LPC various ~II 
y 78.4 PS, Ca, DG, FFA, LPC brain 
grp B, NovellNew 
{} 77.5 PS, DG, PIP2 ubiquitous 
E 83.5 PS, DG, FFA, P1P2 brain 
T) 78.0 CS, PIP2 lung, skin, heart 
e 81.6 ? skeletal muscle 
grp C, atypical 
~ 67.7 
PS, FFA, PIP3• CER ubiquitous 
AIL 67.2 ? ovary, testis 
Table 1. The Mammalian PKC Superfamily. The mammalian PKC superfamily is 
currently made up of 11 isoenzymes that are grouped together on the basis of lipid cofac-
tor requirements and structural homology. All PKC isoenzymes are single polypeptide 
phosphoproteins with molecular weights that range between 67-84 kDa and representa-
tives of each subfamily are found in all eukaryotic cells. There is an absolute requirement 
for phospholipids for PKC activity. 
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Structure of PKC's 
- PK i a family of erine-threonine kinase con i ting of two well defined 
tructural domain: a N-terminal regulatory domain and a C-terminal catalytic domain 
I Regulatory Domain I r-- Catalytic Domain 
L-Cl~ 
Cl domain - DAG PMA binding domain 
C2 domain - Ca2+, pho pholipid binding domain 







vs C, £ Y) , e 
vs atypical 
~ L/'A 
Figure 1.1 Structure of the PKC superfamily. All PKC family members contain 
the highly conserved (approx. 85% homology) carboxy terminus catalytic domain 
and an amino terminus regulatory domain that is made up of various complements 
and compositions of lipid binding modules. 
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- PKC ~II has three major phosphorylation sites: Thr5OO, ThrMl. and Ser660 




Figure 1.2 Scheme for regulation of cPKC through phosphorylation at conserved 
serine-threonine residues. Nascent cPKC beta2 is phosphorylated at T500 by 
phosphoinositide-dependent kinase- I and this is required for autophosphorylation at 
threonine 641 and serine 660. Phosphorylation at T641 is necessary for catalytic com-
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Figure 1.3 Lipid dependent translocation of PKC to the cell membrane. Agonist 
binding to a cell surface receptor (e.g. G-protein c upled receptor. receptor tyrosine 
kinase) triggers the activation of a PI-specific phospholipase C. The hydrolysis of PIP2 
leads to the formation of membrane-bound DAG and soluble IP3. IP3 diffuses to the 
endoplasmic reticulum where is binds receptors that release incellular stores of cal-
cium. The increase elevation of calcium along with DAG act in concert to recruit PKC 
to the plasma membrane. DAG-derived from PI lipid hydrolysis is rapidly metabolized 
and PKC reverses translocation within 1-2 min. Agonist binding can also activate PC-
specific phospholipase D. DAG, which can be ustained for hours, is proposed to re-
cruit PKC to the membrane in a mechanism analogous to PI-derived DAG but with a 
more persistent association with the membrane. 
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Chapter 2: Role of a Novel cPKC-Dependent Compartment in the Sequestration of 
Recycling Membrane Components 
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2.1 Introduction 
Members of the Protein Kinase C (PKC) superfamily of lipid-dependent, serine-threonine 
kinases function as critical signaling intermediates in numerous signal transduction pathways 
and cellular regulatory processes. Currently, PKC consists of 11 distinct isoenzymes grouped 
into three subfamilies (classical, novel, and atypical) on the basis of lipid cofactor 
requirements and structural homology (Ohno and Nishizuka, 2002). Each PKC isoenzyme 
can be divided into two functional domains; a highly conserved carboxy terminus domain 
that encodes the subdomains required for catalytic activity~ and a less conserved, amino 
terminus which contains the lipid binding modules that determine subfamily-specific lipid 
requirements. The first PKC kinases to be identified were the calcium-dependent or classical 
PKC (cPKC) isoenzymes (u, ~I, ~II, and y). Members of this subfamily contain a cysteine-
rich zinc finger Cl don1ain which is the site of sl1-1 ,2-diacylglycerol (DAG) and phorbol 
ester binding, and a C2 domain which confers calcium-dependent phospholipid binding 
properties. The novel PKC (nPKC) isoenzymes (6, E, 11, 8) contain a C 1 domain sin1ilar to 
the classical isoenzYlnes but are calcium-independent due to a truncated, non-functional C2 
domain. Lipid regulation of the atypical PKC (aPKC) subfamily ('All, (;) is the most divergent 
due to a truncated, DAG-insensitive C I domain and no C2 domain. (MeJIor and Parker, 
1998; Newton and Johnson, 1998; Ohno and Nishizuka, 2002). 
A key determinant of ceJJular PKC activation lies in the ability of individual isoenzymes, 
especially the cPKC's and less so the nPKC's, to 'translocate' to plasma membrane in response 
to DAG and tun10r-pron10ting phorbol esters. At the plasma membrane, PKC is activated 
and gains access to specific substrates (Nishizuka, 1995). Although this classical model of 
acute PKC activation (seconds to minutes) stands today as a paradigm for the study of lipid-
dependent signal transduction, there is additional biochemical and immunocytochemical 
evidence to suggest that PKC may translocate to sites other than the plasma membrane 
(Mochly-Rosen and Kauvar, 1998). Using a variety ofPKC agonists, including extracellular 
agonists and phorbol esters, PKC has been localized to the Golgi complex (Goodnight et 
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aI., 1995), nuclear envelope (Hocevar and Fields, 1991; Leach et aI., 1989), nucleus 
(Beckmann et aI., 1994; Neri et aI., 1994) mitochondria (Majumder et aI., 2000), and/or 
cytoskeleton (Blobe et a1., 1996a; Ito et aI., 1989; Mochly-Rosen et a1., 1990). Translocation 
of PKC into the nucleus occurs in response to the agonist-mediated turnover of nuclear PI 
lipids and the subsequent generation ofDAG (for a recent review on nuclear inositol signaling 
and PKC in the nucleus see (MarteJJi et a1., 2002) and (MarteJJi et aI., 2001)) 
In the course of investigating the mechanisms of PKC translocation, we observed that 
foJJowing relatively long term treatments (>45mins) select PKC isoenzymes translocated. 
to a singular, juxtanuclear location. In this study, we present data describing the translocation 
of menlbers of the cPKC subfamily to a novel, temperature- and kinase activity-dependent 
derivative of the endosomal recycling system, which was found to be closely associated 
with the Golgi complex and nlicrotubule-organizing center (MTOC). These data also suggest 
that translocation of PKC to this compartment coincides with an enrichment of this 
compartnlent in lipid raft components and that this compartment functions to sequester 
recycling components. 
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2.2 Materials and Methods 
Materials 
Eagle's minimal essential media, Dulbecco's modified Eagle's mediulTI, and HEPES were 
from Life Technologies, Inc (Gaithersburg, MD). The HeLa and DLD-1 cell lines were 
kindly provided by Dr. Dennis Watson (Medical University of South Carolina), and the 
CHO-KI cell line was kindly provided by Justin Turner (Medical University of South 
Carolina). The HEK 293, HT-1 080, COS-I, and A549 cell lines were all purchased from 
American Tissue Culture Collection (Manassa, VA). Primary antibodies: Anti-cPKCa was 
described previously (Wetsel et aI., 1992); Anti-20S ProteasOll1e (cat #539145), 4~-phorbol-
12-myristate-13-acetate (PMA) and 4a-phorbol were purchased from Calbiochem (La Jolla, 
CA.); anti-pericentrin (cat # PRB-432C) and anti-giantin (cat # PRB-114C) were from 
Covance (Oakland, CA); anti-GM130 (cat # 610822) and anti-p230 (cat # 611280) were 
purchased from BD Transduction Labs (Lexington, KY); anti-rab II (cat # 9020) and anti-
Ubiquitin (cat # FL-76) were obtained from Santa Cruz (Santa Cruz, CA). Alexa Fluor®-
594 Transferrin, Alexa Fluor®-594 Cholera Toxin, anti-nlouse and anti-rabbit TRITC 
secondary antibodies were froln Molecular Probes, Inc (Eugene, OR.). All other chemicals 
were from Signla (St. Louis, MO). 
Cell culture conditions 
HeLa, Cos-1, and A549 cells were maintained in Dulbecco's 1110dified Eagle's ll1edium 
(DMEM), HEK 293 and HT-l 080 cells were maintained in Eagle's minimal essential media 
(MEM), DLD-I cells was maintained in RPMI-1640, and CHO-Kl cells were maintained 
in Ham's FI2K. All media (GIBCO-BRL) were supplemented with 10% (v/v) fetal bovine 
serum (Summit), 100 U/ml penicillin, and 1 00 ~g/ml streptolllycin. Cells were grown at 




The subcloning of full length wild-type cPKC~II, cPKC~II-mtC1, and cPKC~II-~C2 into 
pBK-CMV-GFP was described previously (Feng et aI., 2000; Feng et aI., 1998). GFP-
fusion constructs of cPKCu and nPKCE were prepared using a similar method; cDNA was 
amplified with palyermase chain reaction (PCR) and gene specific primers synthesized 
with a 5' BssH II and 3' Kpn I restriction site. The amplified peR products were digested 
and ligated into the pBK-CMV-GFP mamnlalian expression vector. The GFP-cPKC~II-C 1 
domain was produced by amplifying the C 1 donlain of cPKC~II with PCR prinlers containing 
restriction sites. Amplified product was ligated into the pEGFP-C3 vector (Clontech). A 
full length human EST encoding wild-type atypical PKC zeta was purchased from Alnerican 
Type Culture Collection (Rockville, MD) and amplified with PCR. Atypical PKC zeta was 
amplified with primers encoding a 5 ~ Xhol restriction site and an 3' Eca RI site. The anlplified 
full length, wild-type PCR product was ligated into pEGFP-C3 vector (Clontech) and 
sequenced at the MUSC DNA Sequencing Facility. 
Transient transfection, indirect immunofluorescence, and confocal microscopy 
Cells were plated onto 35 mm confocal dishes (MatTek) at a density of 2.5-5.0 x 10-5 cellsl 
dish and grown for 24 hours. Transient transfection of DNA (1.5 ~g/dish) was performed 
with Lipofectamine 2000 (Invitrogen) according to manufacturer's recommendations. 
Twelve hours post transfection, cells were treated and fixed with 3-3.70/0 paraformaldehyde 
with or without 100/0 methanol for 10 minutes at 37°C or room temperature. FolJowing 
fixation, cells were permeabilized with -20°C 1000/0 methanol for 10 minutes. The methanol 
was aspirated and cells were allowed to air dry (approx. 5 minutes). CeI1s were washed 3 
times with 1.50/0 FBS/PBS for 5 minutes each and then blocked in 2.50/c FBS for 1 hour at 
room temperature. All primary antibody incubations were perfornled in 1.50/0 FBS/PBS 
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with 0.] 5% saponin at dilutions of 1 :50 to I : 100 for 3 hours at rooln temperature or overnight 
at 4°C. Following incubation with the primary antibody, cells were washed 3 tin1es with 
1.S% FBSIPBS for 5 minutes each. Cells were incubated with secondary antibody diluted 
in ] .S% FBS/PBS and 0.15% saponin at a dilution of 1 :50 to 1: 100 for one hour at room 
temperature. Cells were washed 3 additional times with 1.S% FBS/PBS for S minutes each. 
Confocal images were captured immediately following immunofluorescence processing 
with an Olympus IX-70 Spinning Disk Confocal Microscope and a PLAN APS 60x (NA. 
1.4) oil objective. Each micrograph represents a single image captured at the equatorial 
plane of the cell. All micrographs were processed for publication in Adobe Photoshop® 
S.O. 
Disruption of the Goigi complex with nocodazole and brefeldin A 
The Golgi dissociating agents, nocodazole and brefeldin A were employed to probe cellular 
localization of cPKC. Cells were plated in 3S mm confocal dishes (MatTek) at a density of 
2.S-S.0 x 10-5 cells/dish. After 24 hours of growth, ce]]s were transiently transfected with 
GFP-cPKCa. Twelve hours post transfection, cells were treated with ] 00 nM PMA for 1 
hour at 37°C to induce the translocation of cPKCa to the pericentrion. Following this 
initial cPKC stimulation, cells were then treated with concentrations of either nocodazole 
(S ~M) or brefeldin A (S ~g/ml) that were previously (Cole and Lippincott-Schwartz, 1995; 
Klausner et aI., 1992) determined to cause full Golgi dissociation which was also verified in 
this study (Fig. 4B and D). 
Electron Microscopy 
HEK 293 cells were plated onto 35 mm dishes at a density of 2.5-S.0 x 10-5 cells/dish. After 
24 hour of growth, cells were either treated with 0.01% DMSO or 100 nM PMA for 1 hour. 
Cells were fixed for electron microscopy in pre-warmed, 2.S% glutraladehyde-O.l M sodium 
cacodylate for 30 minutes at 37°C and then rinsed overnight in cacodylate buffer with 70/0 
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sucrose. Cells were post-fixed in 1 % osmium tetroxide and 1 % potassium ferrocyanide for 
1 hour. Potassium ferrocyanide was included along with osmium tetroxide to enhance 
staining of membrane structures. Cells were then dehydrated in graded ethyl alcohol as 
follows: 5 min in 50% ethyl alcohol, 5 Inin in 700/0 ethyl alcohol, 5 min in 950/0 ethyl 
alcohol, and IO min in 1000/0 ethyl alcohol. Samples were infiltrated with a 1: I solution of 
1000/0 ethyl alcohol and Embed 812 embedding resin for 30 min and then embedded in 
Embed 812 resin. Samples were polymerized for 24 hour in a 60°C oven with cover on dish 
and 24 hour at 60°C without dish cover. The hardened resin was separated from the plastic 
dish and blocks were cut with a Sears electric scroll saw. Blocks were re-enlbedded for 
orientation and polymerized for a 24 h at 60°C. Thick sections (0.5 ~lm) were cut, stained 
with toluidine blue and exanlined with light microscopy to determine which blocks were 
appropriate for thin sectioning. Thin sections (70 nm) were cut with a Riechert 
Ultramicrotome Ultracut E, picked up on copper grids, and double-stained with uranyl acetate 
and lead citrate. Thin sections were viewed with a lEOL 12] 0 Transnlission electron 
microscope at 80 k V. Images represent the average appearance of a minimum of 20 high 
power magnification fields. 
Immunoelectron Microscopy 
A pre-embedded ilnmunoelectron microscopic approach was modified from Ohta et a1. (Ohta 
et aI., 2002) for these studies. Briefly, cells were plated in 35 nlm dishes at a density of 2.5 
to 5.0 x 10-5 cells/dish. Twenty four hours later cells were treated either with 0.01% DMSO 
or 100 nM PMA for 1 hour, washed 3 times with PBS, and then fixed with 30/0 fornlaldehyde 
in pre-warmed Pipes pH 6.8 for 20 minutes at 37°C. Cells were permeabilized with 0.5% 
Triton X-IOO in Pipes pH 6.8 for 10 minutes at room tenlperature and washed 3 times with 
PBS for 10 minutes each at room temperature. Non-specific binding was blocked with 100/0 
BSA in PBS with 0.05% Tween-20 for 60 minutes at 37°C. The primary antibody (anti-
cPKCa) was diluted to 1 :50 in 1.5% FBS/PBS with 0.15% saponin and incubated for 2 
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hours at 37°C. Cells were washed 3 times for 10 minutes each with PBS/O.OS% Tween-20 
at room temperature. The anti-rabbit IgG secondary antibody conjugated to 12 nm colloidal 
gold (Jackson ImmunoResearch) was diluted 1: 10 in I.S% FBS/PBS with O.IS% saponin 
and incubated at 37°C for 5 hours. Cells were washed 3 times for 1 0 minutes each with 
O.OS% Tween20/PBS at room temperature and then fixed a second time with 2.50/0 
glutaraldehyde in Pipes pH 6.8 for 60 minutes. Further processing for immunoelectron 
microscopy was carried out as described above for electron microscopy. 
Steady state labeling with transferrin 
Cells were plated onto 35 mm confocal dishes at a density of 2.S-S.0 x 10-5 cells/dish, 
grown for 24 hours, and then transiently transfected with GFP-cPKCa. Twelve hours post 
transfection, visualization of total cellular recycling compartn1ents was achieved by steady 
state labeling cells with 10 !-1g/ml Alexa Fluor (594)-conjugated transferrin (Molecular 
Probes) for 60 minutes in the presence of 0.0 10/0 DMSO or 100 nM PMA. AlllabeJing was 
performed in the presence of complete culture media with 100/0 FBS. 
Recycling assay 
Cells were plated onto 3S 111m confocal dishes at a density of 2.5-5.0 x 10-5 cells/dish, 
grown for 24 hours, and then were transiently transfected with GFP-cPKCa. Twelve hours 
later, the recycling of membrane components was visualized by chase labeling of transfected 
cells with 1 0 ~g/ml of unlabelled transferrin for 30 minutes following a 1 hour steady state 
labeling of cells with 1 0 ~g/ml Alexa Fluor-conjugated transferrin. The steady state labeling 
and subsequent chase with unlabelled transferrin were performed either in the presence of 
0.010/0 DMSO or 100 nM PMA. All images represent the average appearance of a n1inimum 
of 20 60X fields from 3-5 separate experiments. 
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2.3 Results 
2.3.1 Endogenous and overexpressed PKC translocates to ajuxtanuclear location when 
stimulated in a prolonged manner. 
Whereas acute (5-10 mins) stimulation of PKC with its agonist 4~-phorbol-12-myristate-
13-acetate (PMA) results in translocation of PKC to the plasma membrane, longer PMA 
treatments (>45 mins) ofHela celIs resulted in the translocation of both endogenous cPKCa 
and GFP-fused cPKCa to the plasma membrane and, to a singular, juxtanuclear region 
(Fig. 2.1 A). The inactive phorbol ester analogue, 4a-phorbol, did not result in translocation 
of PKC to either the plasma membrane or the juxtanuclear region (Fig. 2.1 B), and 
translocation of cPKCa was not limited to activation by phorbol esters since the non-phorbol 
PKC activator 7-octylindolactam, was also able to induce translocation of GFP-PKCa to 
the juxtanuclear region (data not shown). To investigate whether juxtanuclear translocation 
was limited to HeLa cells, GFP-cPKCa was transiently transfected into a variety of other 
cell lines, and the cells were treated with PMA for 60 min. Juxtanuclear cPKC translocation 
was observed in several cell lines including HEK 293, HT-1 080, DLD-1 (Fig. 2.1 C), CHO, 
COS-I, and A549 adenocarcinoma cells (data not shown) indicating that translocation of 
PKC to this site represents an ubiquitous response to sustained activation. Thus, cPKCa 
undergoes translocation to a novel, juxtanuclear location upon prolonged stimulation with 
various PKC agonists. 
2.3.2 Translocation ofPKC to the juxtanuclear compartment is specific for the classical 
PKC isoforms, a and flII 
To determine if translocation of cPKCa to the juxtanuclear location was isoenzyme-specific 
or was common to all isoenzymes, representatives of each PKC subfamily (classical - ~II, 
novel - E, atypicals - (;) were subcloned into GFP vectors and transiently transfected into 
HeLa cells. Following 1 hour exposure to PMA, only GFP-cPKC~II was observed to 
translocate to both the plasma membrane and to the juxtanuclear site (Fig. 2.2A). The 
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DAG-sensitive and calciun1-independent nPKC isoenzyme GFP-nPKCE was found only at 
the plasma membrane, whereas the DAG-insensitive GFP-aPKC~ did not respond to PMA 
and exhibited no alteration in cytoplasmic localization. These data suggest that the 
translocation of cPKC to the juxtanuclear region involves a mechanism that appears restricted 
to members of the calcium- and DAG/PMA-sensitive cPKC subfamily. 
2.3.3 Juxtanuclear translocation of cPKC requires Cl and C2 domains 
To investigate the requirement of the C 1 and/or C2 domain in translocation of cPKC 
isoenzymes to the juxtanuclear compartment, a series of cPKC mutants were generated 
encoding either a mutant of the C 1 domain (cPKC~II-mtC 1) that disrupts binding of DAG/ 
PMA, a full deletion of the C2 domain (cPKCf3II-L\C2), and an isolated C 1 domain (GFP-
C 1) of cPKCf3II. One hour treatment with PMA lead to translocation of wild-type GFP-
cPKC~lI to both the plasma membrane and juxtanuclear, whereas the diffuse cytoplasmic 
localization of cPKCf3II-mtC 1 was unchanged (Fig. 2.2B, panels 1 and 2). This suggests 
that cPKC translocation to the plasma membrane requires a functional interaction with its 
agonist at the C 1 domain. Importantly, GFP-C 1 exhibited translocation to the plasma 
membrane as has been previously reported (Oancea et aI., 1998) but no translocation to the 
juxtanuclear region was evident (Fig. 2.2, panel 3). This suggested that binding to the 
phorbol ester alone was not sufficient to induce translocation and that translocation may 
require full length protein. To that end, similar to the isolated C 1 domain, the GFP-cPKCf3II-
~C2 exhibited translocation to only the plasma membrane (Fig. 2.2, panel 4). These results 
suggest that translocation of cPKC requires both a C 1 and C2 domain. In subsequent studies, 
the cPKCa and (311 isoforms were found to behave identical in parallel experiments, and 
therefore, for extended investigation we chose to focus on the cPKCa isoenzyme. 
40 
2.3.4 cPKCa translocates to a singular, juxtanuclear location distinct from the Goigi 
complex 
In an effort to identify the juxtanuclear compartment to which cPKC translocated, an extensive 
colocalization study was undertaken. As expected, given that cPKC translocates to a singular 
location in the center of the cell, the mitochondria-specific dye, MitoTracker, the late 
endosome/lysosomal-specific dye, LysoTracker, and an ER-targeted protein, pDS-Red-ER, 
all failed to display any overlap with GFP-cPKCa translocated to the juxtanuclear region 
(data not shown). Translocation of cPKC to a central region of HeLa or HEK 293 cells 
suggested that, under conditions of prolonged stinlulation, cPKCa may associate with an 
organelle that can also be found as a single compartlnent such as the Golgi complex. This 
was thought to be a strong possibility since the cPKCy isoform was suggested to localize to 
the golgi complex in the NIH 3T3 cell line following long term activation with PMA 
(Goodnight et aI., 1995). In addition, some DAG/PMA-sensitive, non-kinase proteins, 
including munc 13 (Song et aI., 1999) and chimaerins (Caloca et aI., 2001) have also been 
reported to translocate to the Golgi complex following activation with phorbol esters. Using 
antibodies to GM 130 (Nakamura et aI., 1995), giantin (Linstedt and Hauri, 1993), and p230 
(Kooy et aI., 1992), as markers of the cis, medial, and trans compartments of the Golgi 
complex, respectively, GFP-cPKCa was observed to localize close to the Golgi compartment 
at low magnification (Fig. 2.3 A-C, rows 1 and 3)). However at higher magnification and 
resolution, it was evident that the pattern of cPKC translocation was separable from the 
Golgi complex (Fig. 2.3 A-C, rows 2 and 4). Analysis of high resolution micrographs 
revealed that GFP-cPKCa translocated to a region of the cell that was surrounded by the 
Golgi complex but displayed only minimal overlap with that organelle. In order to 
conclusively rule out any association of cPKCa with the Golgi, the Golgi cOlnplex was 
disrupted with 5 ~g/ml Brefeldin A (BFA) (Klausner et aI., 1992). Total disruption of the 
Golgi complex was indicated by dispersal of GM 130 visualized by indirect 
immunofluorescence (Fig. 2.4A). However, BFA had little effect on cPKCa translocated to 
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the juxtanuclear site (Fig. 2.4B). It has been reported that BFA may incompletely disrupt 
the Golgi complex and that the cis/medial Golgi dissociates, but the trans-Golgi remains 
intact (Ladinsky and Howell, 1992). To address this possibility, cells were treated with 5 
~M nocodazole which effectively disrupts all aspects of the Golgi complex following 1 
hour PMA (Cole and Lippincott-Schwartz, 1995)(Fig. 2.4C). The administration of 
nocodazoJe had no effect on the GFP-cPKCa associated with the juxtanuclear site (Fig. 
2.4D). Quantitation of the effect of both nocodazole and BFA cPKC translocation showed 
that there was only modest effects on the number of cells exhibiting juxtanuclear translocation 
(Fig. 2.4E). Thus, the apparent resistance of this compartment to BFA and nocodazole-
induced disruption suggests that cPKCa translocated to an organelle distinct from the Golgi 
complex and whose structure was independent of microtubules. These results argue against 
the localization of cPKCa to the Golgi complex upon prolonged activation. 
2.3.5 The juxtanuclear accumulation of cPKC is not a result of aggregated or degraded 
protein. 
Recent reports suggest that the excess production of misfolded proteins may result in the 
aggregation of protein in an MTOC-associated structure which the authors named the 
4aggresome' (Garcia-Mata et a1., 1999; Johnston et a1., 1998). The aggresome consists of 
aggregated protein encased in a vimentin-supported structure that functions to recruit 
cytosolic pools of ubiquitin and proteasome subunits to aid in the degradation of misfolded 
proteins (Wigley et aI., 1999). In our studies, no evidence was found that overexpression 
of GFP-tagged cPKC isoenzymes and/or long term treatment with PKC agonists could 
modulate the subcellular location of ubi quit in or the 20S proteason1e (Fig. 2.5A and B), and 
thus, cPKCu did not colocalize with either ubiquitin or 20S proteasome. Further, no PKC 
degradation was detected up to 6 hours for either endogenous (Fig. 2.5C) or overexpressed 
protein (data not shown), although some loss of PKC was seen at later time points. Thus, 
within the time frame of the current studies (1 h) there was no detectable degradation of 
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PKC 
Importantly, cPKCa translocation to the juxtanuclear compartment was found to be 
reversible and temperature dependent such that stimulation at 37°C resulted in the 
translocation of GFP-cPKCa to the juxtanuclear compartment; however, at lower 
temperatures (4-30°C), this translocation was not observed (Fig. 2.50, panel 1-3). Also, 
juxtanuclear translocation of cPKCa could be fully reversed with subsequent incubation at 
4°C and then restored following reincubation at 37°C (Fig. 2.50, panel 4-5). These results 
demonstrate that cPKC translocation and association with the juxtanuclear compartment 
involves a dynamic and reversible interaction and not the aggregation of protein. Moreover, 
they emphasize the high dependence of translocation on physiologic temperature. 
2.3.6 cPKCa translocates to a compartment that is closely associated with the 
centrosome. 
The centrosome or the 'central body' named by Theodor Boveri nlore than 100 years ago 
can be found at the center of interphase ce]]s where it functions as the primary MTOC 
(Rieder et aI., 2001). Due to its central location, the centrosome became a candidate for the 
novel compartment defined by cPKC translocation. Indirect immunofluorescence with 
markers of the centrosome demonstrated that GFP-cPKCa translocated to a compartlnent 
that was centrally defined by gamma tubulin (data not shown) and pericentrin (Doxsey et 
aI., 1994)(Fig. 2.6A). However, it was evident that GFP-cPKCa localization extended 
significantly beyond the pericentrin-defined centrosome. These observations suggested 
that with long tenTI activation, cPKCa translocates to a novel compartment located in a 
central region of the cell and that this compartment was closely associated with the 
centrosome. 
2.3.7 cPKCa translocates to a subset of transferrin-positive recycling endosomes 
Based on the above evidence, we evaluated compartments/cellular functions that show 
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pericentriolar behavior. Although the endosomal recycling compartment (ERC) usually 
shows a diffuse tubulo-vesicular morphology, in some cells a subcomponent of the recycling 
compartment adopts a singular pericentriolar distribution, closely related to the Golgi complex 
and MTOC (McGraw et aI., 1993; Yamashiro et aI., 1984); however, this distribution has 
not been shown to be associated with any known specific functions or regulation of the 
recycling compartment (McGraw et aI., 1993; Mukherjee et aI., 1997). To determine if 
cPKCa localized to any aspect of the endosomal recycling system, we examined the effects 
of PMA on transferrin recycling and its relationship to PKC. Cells were labeled to steady 
state with Alexa Fluor® 594-conjugated, fluorescent transferrin (AF-Tty and treated with 
phorbol esters. As shown in Fig. 2.6B, sustained activation of PKC resulted in localization 
of cPKCa to a subset of transferrin-positive recycling endosomes concentrated in a central 
area of the cell suggesting that cPKC translocated to the component of the recycling systenl 
associated with the MTOC/centrosome. Currently, the best markers for the pericentriolar 
recycling compartInent (PCRC) include RME-1 (Lin et aI., 2001) and the small GTPase, 
rab 1 I (Ullrich et aI., 1996). Indeed, GFP-cPKCa was found to have extensive colocalization 
with rab 1] at the juxtanuclear compartment (Fig. 2.6C). These studies suggest that cPKC 
may associate with a specialized subcompartment of the endosomal recycling system or a 
derivative of this system. 
However, unlike rab 11, which was present at the juxtanuclear region and in the lnembrane 
fraction independent of temperature or PMA activation (Fig. 2.6D-F), cPKCa was not a 
resident component of this compartment, but actively translocated to it in a temperature-
and activation-dependent process, suggesting that the cPKC-defined compartment is not 
identical to the rab II-defined one but closely associated with it. 
2.3.8 Translocation of cPKCa to the pericentrion is accompanied by membrane lipids 
and proteins. 
Since activation of PKC by phorbol esters involves an association with membrane lipids we 
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next evaluated if the translocation of cPKCa to the juxtanuclear region was accompanied 
by membrane lipids. Utilizing a fluorescent analogue of the ganglioside GM 1 (bodipy-
OM 1) as a plasma membrane marker, it was observed that in the absence of PKC stimulation, 
OM 1 was localized predominantly to the plasma membrane (Fig.2.7 A, panel 1). Following 
1 hour PKC stimulation, GM 1 was found in the plasma membrane and also at a juxtanuclear 
location (Fig. 2.7 A, panel 2), and similar to cPKC the trafficking ofGM 1 to the juxtanuclear 
site was also highly dependent upon temperature (Fig. 2.7B). Quantitatively, approximately 
500/0 of the Bodipy-GM 1 that loaded into the membrane in the absence of PKC stinlulation 
accunlulated at the juxtanuc]ear compartment upon PMA stimulation. To confirm that GM 1 
accumulated in the cPKC-positive juxtanuclear compartment, cells were labeled with the 
fluorescent, GM I-binding, cholera toxin B subunit (AF-CTx-B) in the absence or presence 
of phorbol esters. Following 1 hour stimulation of PKC, AF-CTx-B colocalized with GFP-
cPKCa in the juxtanuclear compartnlent (Fig. 2.7C). Similar to cPKC and GM 1, AF-CTx-
B also displayed temperature dependent translocation (Fig. 2.7D). Interestingly, CTx-B 
accumulated at the juxtanuclear compartment independent of stimulation with phorbol esters~ 
however, the addition of CTx-B also caused accumulation of cPKCa at the juxtanuclear 
compartment (data not shown). Further, treatment with Go 6976, a cPKC-selective kinase 
inhibitor, caused the dissociation of AF-CTx-B from the juxtanuclear compartment following 
accumulation at the juxtanuclear location (Fig. 2.7E). These data show that CTx-B activates 
cPKC and that cPKC kinase activity is required for maintenance of this compartment. 
Thus, cPKCa translocation involves plasma membrane lipids, suggesting the translocation 
of at least subcompartnlents of the plasma membrane. This was further evaluated by 
following the simultaneous localization of caveolin-1, a plasma membrane protein and a 
key constituent of caveoli (Glenney and Soppet, 1992). Long term stimulation of cells with 
PMA resulted in the concentration of caveolin-l at the pericentriolar region and colocalization 
of cPKCa with caveolin-I (Fig. 2.7F). These observations suggest that cPKC translocates 
to a subcompartment of the endosomal recycling system that is enriched in components of 
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lipid rafts/caveolae and that kinase activity is required for maintenance of this compartment. 
Lipid rafts have recently emerged as distinct subdomains of the plasma membrane that 
function as platfornls for the signal transduction of raft -associated receptors and enzymes 
{for a recent review see (Simons and Toomre, 2000)). The above results demonstrate dynamic 
regulation of plasma membrane rafts by cPKC. 
2.3.9 Translocation of cPKCa to the juxtanuclear compartment coincides with the 
formation of a pericentriolar membranous structure. 
Despite data describing the pericentriolar conlponent of the recycling compartment 
(Mukherjee et aI., 1997; Yamashiro and Maxfield, 1987; Yamashiro et aI., 1984), little 
ultrastructural information is available defining this compartment. Moreover, the active 
translocation of PKC, caveolin, membrane lipids, and presumably other membrane 
constituents to this compartment and the requirement for PKC activity in this process suggest 
that a distinct compartment, containing membrane structures should exist. In an effort to 
better visualize this compartment, an electron microscopic approach was undertaken. Noting 
the exquisite dependence of cPKCa association on temperature we suspected that this 
compartInent nlay disperse at room temperature (or temperatures lower than 30°C). Thus, 
speciaJ care was used to maintain the temperature at 37°C during preparation of ceBs for 
electron nlicroscopy. In addition, the presence of a melnbranous structure also suggested 
the need to optinlize preparatory conditions for the best visualization of internal membranes. 
To that end, the membrane enhancing stain potassium ferrocyanide was included along 
with osmium tetroxide to accentuate membranes (Karnovsky, 1971). In untreated cells, the 
centrosome was seen as the expected 400 nm structure surrounded by 50-80 nm vesicles 
and tubular structures with golgi complex seen in the surrounding periphery (Fig. 2.8A). 
Stimulation of PKC with PMA resulted in a reorganization of the centrioles, with an extension 
of the centrioJar appendages and an appearance of a membranous structure that seemed to 
radiate from these appendages in multiple concentric membranes (Fig. 2.8B). Immunogold 
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experiments localized cPKCa to these centriolar-associated Inembrane structures (Fig. 2.8C) 
and in a perilneter surrounding each centriole (Fig. 2.8D). To our knowledge, this is the 
first time that a membranous structure has been visualized associated with the centrosome. 
This Inay have previously been missed due to lack of potassium ferrocyanide usage, failure 
to maintain appropriate temperature, and to the requirement for prolonged cPKC activation. 
2.3.10 Long term activation of cPKC results in the sequestration of membrane recycling 
components. 
Next we explored the biological consequences of the translocation of cPKCa to this 
compartment. The endosolnal system is known to function as a sorting center for proteins 
and lipids destined for degradation in lysosomes, trafficking to other organelles, or recycling 
back to the plasma nlenlbrane (Mukherjee et a1., 1997; Mukherjee and Maxfield, 2000). 
Since the trafficking of transferrin has been the subject of extensive study (Yamashiro et aI., 
1984), we examined the effects of stimulation and inhibition of PKC on the kinetics of 
endocytic membrane trafficking using the fluorescent-conjugated transferrin ligand (AF-
Tf). Steady state labeling of cells with AF-Tf, in the absence of PKC activation, resulted in 
the localization of transferrin in a broad, pericentriolar pattern (Fig. 2.9A), which is consistent 
with previous results (Yamashiro et aI., 1984). On the other hand, when cells were steady 
state labeled with transferrin in the presence of PMA, the pericentriolar localization of 
transferrin intensified and GFP-cPKCa was observed to colocalize with this pericentriolar 
subset of transferrin positive compartments (Fig. 2.9B). Since kinase activity is required 
for the maintenance of the cPKC-dependent juxtanuclear compartment, the effects of kinase 
inhibitors were evaluated. As seen in Fig. 2.ge, preincubation with 3 !-lM Go 6976 did not 
block uptake of AF-Tf, but there was an absence of any pericentriolar intensity. Go 6976 
also inhibited the translocation of GFP-cPKCa. These data suggest that, under conditions 
where cPKC activity is sustained for a prolonged period, there may be a reorganization of a 
subset of recycling endosomes to the pericentriolar region. 
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To investigate the functional consequences of sustained cPKC activity on membrane 
recycling, chase experiments were performed with non-fluorescent transferrin. In the absence 
of PKC stimulation, a 30 minute chase foJlowing steady state labeling with AF-Tf resulted 
in the recycling of all transferrin back to the plasma membrane and a complete loss of 
fluorescence from the cell (Fig. 2.9D), again consistent with published results (Dunn et a1., 
1989; Hopkins and Trowbridge, 1983; Mayor et aI., 1993). In stark contrast, a 30 minute 
chase in the presence of sustained cPKC activity resulted in the retention of AF-Tf in the 
cPKC positive juxtanuclear compartment (Fig. 2.9E). These observations demonstrate that 
cPKC can effectively sequester recycling components in this juxtanuclear compartment. 
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2.4 Discussion 
This study shows that unlike the classical model of PKC activation, in which PKC responds 
to the acute elevation of lipid second messengers with a reversible (30-120 seconds) 
translocation to the plasma membrane, a more prolonged stimulation can induce translocation 
to a site which is centered on the centrosome but extends beyond it. This compartnlent is 
most closely related to a previously recognized variant of the endocytic recycling 
compartlnent (ERC) which can be found in some cells concentrated in an area around the 
MTOC/centrosome. Currently there is no known function associated with this specific 
distribution of ERC. However, there are several distinctions between the cPKC-positive 
compartment and the typical ERC: 1) unlike rab 11, which in our studies was localized to 
the center of the cell regardless of PKC stinlulation, cPKC was found to translocate to the 
juxtanuclear compartment only upon long term activation with PKC agonists. Moreover, 
and unlike rab] I, inhibition ofPKC activity reverted the translocated PKC off the juxtanuclear 
compartment (data not shown). Therefore, unlike the rab 11 compartnlent, this structure is 
dynamically regulated through PKC~ 2) Similarly, the juxtanuclear PKC-dependent structure 
was exquisitely dependent on physiologic tenlperature and was dynanlically and reversibly 
regulated by temperature changes; again unlike what was seen with rab 1 I. 3) The MTOCI 
centrosome distribution of the ERC is sensitive to microtubule-disrupting drugs such as 
nocodazole (McGraw et aI., 1993). In contrast, the cPKC-positive compartment was largely 
resistant to the effects of microtubule disruption; 4) Translocation of cPKC was coincident 
with the accumulation of plasma membrane components at this compartment. AccuI11ulation 
of these components at the juxtanuclear compartment was fully dependent upon PKC activity; 
5) Electron and immunoelectron microscopy studies localized cPKC and cPKC-associated 
membranes to the appendages of the centrioles and centrosome and they revealed distinct 
morphologic features seen only upon stimulation with PKC and preservation of 37° C 
temperature. Thus, while cPKC translocated to a pericentriolar compartment that very closely 
overlaps the rab II/MTOC-defined pericentriolar compartment, the above criteria clearly 
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indicate that the two compartments are not identical. 
Given these distinctions, it is apparent that long term activation of cPKCa results in the 
formation of a specialized pericentriolar recycling compartment that serves as a novel target 
for cPKC translocation. In turn, cPKC then functions to regulate the rate of recycling, and 
thus the partitioning of membrane components between this compartment and the plasnla 
membrane. We propose to name this compartment the pericentrion in order to emphasize 
its unique regulation and functional significance (further discussed below). 
Functionally, cPKCa regulates the formation and persistence of the pericentrion with 
attendant sequestration of membrane components in this compartment. This novel function 
ofPKC may be hypothesized to have relevance to many events dependent on the availability 
of membrane components (such as receptors, channels, and transporters) and subdonlains 
(such as rafts) at the plasma membrane. For example, it has been shown that activation of 
PKC regulates the availability of the dopamine transporter at the plasn13 Illembrane (Melikian 
and Buckley, 1999). It would be interesting to determine if these effects are due to retention 
of the dopamine transporter at the pericentrion, in a mechanism similar to that seen with 
transferrin. 
cPKC may also regulate the dynamics of rafts and their function. Rafts are 
glycosphingolipid- and cholesterol-enriched subdomains of the plasma nlenlbrane that 
function to segregate the biochemical activity of associated proteins. A role for lipid rafts 
has been proposed in membrane trafficking and signal transduction (Simons and Toomre, 
2000) From the results in this study, it is obvious that stimulation of cPKC can result in 
movement of key components of caveoli and rafts (caveolin and glycosphingolipids) to the 
pericentrion,. This may result in sequestration of these components with significant 
consequences to the function of rafts and raft-related activities. This should be the subject 
of further investigation. 
In addition to such potential consequences of cPKC-regulated sequestration on the 
function of protein targets at the plasma membrane, it is also possible the concentration / 
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sequestration of specific bioactive lipids and membrane proteins at the pericentrion may 
serve to exert compartment-specific effects. 
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Figure 2.1. Juxtanuclear translocation of endogenous and GFP-tagged classical PKC isoforms 
in various cell lines. (A) Indirect immunofluorescence of endogenous cPKCa and GFP-tagged 
cPKCa in HeLa cells treated with DMSO alone (0.01 %) for 1 hour or 100 nM PMA for 10 minutes 
and 1 hour. Indirect immunofluorescence was performed with anti-cPKCa antibody as described 
in Materials and Methods. Arrows indicate site of juxtanuclear compartment. For overexpression 
studies, HeLa cells were transiently transfected with GFP-cPKCa and 24 hours post transfection 
were treated with DMSO alone or 100 nM PMA. (B) HeLa cells transiently transfected with GFP-
cPKCa were treated 12 hours post transfection with either 100 nM 4~-phorbol or the inactive 4a 
phorbol ester. (C) Transient transfection of various cell lines including HEK 293, HT-1 080, and 
DLD-l with GFP-cPKC alpha. Cells were treated 12 hours post transfection with 1 hour, 100 nM 
PMA. All fluorescent images were captured on an Olympus Ultra View Spinning Disk Confocal 
Microscope IX-70 and each panel is representative of a minimum of 20 fields. All experiments 
were repeated three to five times each with similar results. Bar represents 10.0 J.im. 
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Figure 2.2. Translocation ofPKC to thejuxtanuclear compartment is specific for cPKC 
isoenzymes and requires the Cl and C2 domains. (A) Representative isoenzymes from 
each PKC subfamily (classical, novel, and atypical) were subcloned into pEGFP vector and 
Hela cells were transiently transfected. Twelve hours post transfection, cells were treated 
with 100 nM PMA for 1 hour. (B) GFP tagged wild type and mutants of cPKC~Il; GFP-
cPKC~n, GFP-cPKC~II-mtC1, GFP-Cl domain, GFP-cPKC~n-L1C2, were transiently trans-
fected into HeLa cells and treated with 100 nM PMA for 1 hour. Each panel is the average 
representative of a minimum of 20 fields. All experiments were repeated three to five times 
each with similar results. Bar, 10 JlM. 
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Figure 2.3 Translocation of cPKC isofonns to ajuxtanucIear compartment closely 
associated with Golgi complex and MTOC/centrosome. (A-C, rows 1 and 3) Low 
magnification images of HeLa cells transiently transfected with GFP-cPKCu. 12 hours 
post transfection, cells were treated with 100 nM PMA and subjected to indirect immu-
nofluorescence with anti-Giantin (medial), anti-GM 130 (cis), and anti-p230 (trans). 
Primary antibodies were detected with TRITC-conjugated secondary antibody. (A-C, 
rows 2 and 4) High magnification images of juxtanuclear compartment found in cells 
of rows 1 and 3. Represents indirect immunofluorescence for Golgi markers Giantin, 
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Figure 2.4. The juxtanuclear compartment is resistant to Golgi disrupting drugs (A) Indi-
rect immunofluorescence for GM 130 in He La cells treated with 5 J.ig/ml Brefeldin A for 1 hour. 
(8) HeLa cells transiently transfected with GFP-cPKCu were stimulated with 100 nM PMA for 
1 hour to induce translocation of GFP-cPKCu to the juxtanuclear compartment. Cells were then 
treated with 5 J.iglml BFA for 1 hour to dissociate the golgi complex. (C) Indirect immunofluo-
rescence for GM 130 in HeLa cells treated with 5 J.iM nocodazole for 1 hour. (0) Translocation 
of GFP-cPKCu was induced with 1 hour PMA and followed by 1 hour treatment with 5 J.iM 
nocodazole to dissociate golgi complex. (E) Percentage of total cells exhibiting juxtanuclear 
translocation of GFP-cPKCu following stimulation with 1 hour of 100 nM PMA, 1 hour of 100 
nM PMA followed by 1 hour 5 J.iM nocodazole or 1 hour 5 J.ig/ml BFA. Quantification was 
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Figure 2.5 Accumulation ofGFP-cPKCa at thejuxtanuclear location is not due to aggrega-
tion of PKC. (A) Indirect immunofluorescence for proteasome 20S and (B) ubiquitin in HeLa 
cells following 1 hour DMSO (0.01 %) or 100 nM PMA. (C) Immunoblot for endogenous cPKCu 
in cells treated for 0, 6, 24, and 48 hours with 100 nM PMA. (D, panels 1-3) HeLa cells tran-
siently transfected with GFP-cPKCu were incubated with 100 nM PMA at either 4°C, 30°C or 
37°C for 1 hour. (D, panels 4-5) Cells with juxtanuclear translocation of GFP-cPKCu induced 
with 1 hour PMA at 37°C were then incubated at 4°C for 1 hour or 4°C 1 hour and then 37°C 1 
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Figure 2.6 cPKCa translocates to a subset of transferrin-positive endosomal recycling com-
partments concentrated around the MTOC/centrosome. (A) Indirect immunofluorescence 
with anti-pericentrin in HEK 293 cells transiently transfected with GFP-cPKCa and treated with 
1 hour PMA. (B) Cells were steady-state labeled with Alexa Fluor-conjugated transferrin (A.F.-
Tf) for 1 hour in the presence of 100 nM PMA. (C) Indirect immunofluorescence for endogenous 
rab 11 in cells transiently transfected with GFP-cPKCa and treated with 100 nM PMA for I hour. 
(D) Indirect immunofluorescence for endogenous rab 11 in cells treated with 100 nM PMA for I 
hour at either 4°C, 30°C, or 37°C. (E) Indirect immunofluorescence for endogenous rab II in 
cells treated with either DMSO (0.01 0/0) or 100 nM PMA for I hour. Bar represents 10.0 J.1m. (F) 
Immunoblot of subcellular fractions from cells treated with or without 100 nM PMA for I hour. 
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Figure 2.7 PKC translocates to a juxtanuclear compartment enriched in plasma membrane lip-
ids and lipid raft components. (A) HEK 293 cells were treated with 5 JlM bodipy-GM I complexed 
to BSA for 30 mins at 4°C, washed with ice-cold PBS and incubated at 37°C for I hour in the presence 
of 0.01 % DMSO or 100 nM PMA. (B) Cells were labeled with bodipy-GM I as described above, 
washed with ice-cold PBS, and either jncubated at 4 ° C, 30° C, or 37° C in the presence of 100 nM PMA 
for I hour. (C) Cells were transiently transfected with GFP-cPKCa and 12 post transfection, treated 
with I Jlg/ml of Alexa Fluo~ (594)-cholera toxin-B for 1 hour at 37°C in the presence of 100 nM PMA. 
(D) Cells were treated with 1 Jlglml CTx-B for 1 hour at 4°C, 37°C, 37°C followed by 1 hour at 4°C, or 
37°C followed by 1 hour at 4°C and finally I hour at 37°C. (E) Cells were treated with 1 Jlg/ml CTx-
B for 1 hour to induce accumulation at juxtanuc1ear compartment and then incubated for an additional 
1 hour in the presence of the cPKC selective kinase inhibitor, 3 JlM Go 6976. (F) Indirect immunofluo-
rescence for endogenous caveolin-l in cells transiently transfected with GFP-cPKCa and treated with 
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Figure 2.8 Translocation of cPKCa to the juxtanucIear compartment coincides with the forma-
tion of a pericentriolar membranous structure. Cells were treated with (A) DMSO (0.01 %) or (B) 
100 nM PMA for 1 hour. (B) Treatment of cells with PMA results in the reorganization of centrosome 
structure and the appearance of circumspect membranes (yellow arrowheads) associated with the ap-
pendages of centrioles, and membranous spokes found between appendages (denoted blue arrow-
head). In these studies, potassium ferrocyanide was included along with the osmium tetroxide fixative 
to enhance appearance of membranes, and 37°C was maintained throughout preparation of samples. 
(C and D) Pre-embedded immunoelectron microscopy. Cells were treated with PMA for 1 hour and 
then probed for endogenous cPKCa with anti-cPKCa antibodies followed by incubation with anti-
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Figure 2.9 PKC regulates the sequestration of recycling components in a juxtanuclear com-
partment. Steady state labeling of HEK 293 cells with Alexa Fluo (594 )-conjugated transferrin 
(AF-TO in (A) absence or (B) presence of 100 nM PMA. (C) Cells were transiently transfected with 
GFP-cPKCu. Twenty four hours post transfection, total recycling endosomes were steady state la-
beled with 10 J.lg/ml AF-Tf for 1 hour in the presence of 3 J.lM Go 6976. (D) 30 min chase with 
unlabeled transferrin following 1 hour AF-Tf steady-state labeling in the absence of PMA. (E) 30 
min chase with unlabeled transferrin following 1 hour AF-Tf steady-state labeling in the presence of 
100 nM PMA. Micrographs are representative images from 3 independent experiments. Bar repre-
sents 10.0 J.lm. 
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Chapter 3: Isoenzyme-Specific Translocation of PKC to the Pericentrion Involves 
Activation of Phospholipase D 
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3.1 Introduction 
Members of the protein kinase C (PKC) superfamily of lipid-dependent, serine-threonine 
kinases function as integral signaling intermediates in the transmission of nUlnerous 
extraceJIular signals. PKC currently consists of 11 closely-related isoenzymes that can be 
grouped into 3 subfamilies (classical, novel, atypical) on the basis of lipid cofactor 
requirements and structural homology (Mellor and Parker., 1998). A major form of ceJJular 
regulation ofPKC involves the dynamic redistribution or ~translocation' ofPKC isoenzymes 
from cytosol to the plasma nlembrane. Membrane translocation of PKC is regulated through 
receptor-coupled lipid hydrolases that act on phosphoinositides (PI) and phosphatidylcholine 
(PC) to generate diacylglycerol (DAG) lipid second messengers. The recruitment and 
activation of PKC at membranes links activation of the enzyme to the proxilnity of membrane 
protein substrates (Nishizuka, 1995). 
One of the major targets of activated PKC is PC-specific phospholipase D (PC-PLD). 
Activated PC-PLD hydrolyzes the phosphodiester bond of PC to generate free choline and 
phosphatidic acid (PA) which is converted to DAG through the actions of lipid phosphate 
phosphatase (LPP). DAG derived fronl PC hydrolysis has been proposed to mediate the 
reciprocal regulation of PKC, but there are incomplete and conflicting data on this topic 
(Ha and Exton, 1993; Leach et aI., 1991; Pettitt et aI., 1997). The functional significance of 
PC-PLD-derived DAG is that it is present in the membrane for extended periods of time 
and in relatively high concentrations in comparison to DAG derived from PI-PLC, and this 
PC-derived DAG has been proposed to nlediate long tenn cellular processes that require 
sustained PKC activation (Nishizuka., 1988; Billah and Anthes, 1990). 
The implication of specific PKC isoenzymes in distinct pathological processes has led to 
an intense effort to identify and elucidate the lnechanisnls that regulate isoenzyme-specific 
functions of PKC. To date, these efforts have been complicated by the large nunlber of 
highly homologous PKC family members, expression of nlultiple PKC isoenzymes in each 
cell type, and the finding that there are only minor differences in substrate selectivity amongst 
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different PKCs. 
One the best opportunities to study the mechanisms of isoenzynle specificity arises from 
the alternative splice gene products of the classical PKC (cPKC) ~ gene. Alternative splicing 
of the cPKC~ gene creates two proteins, cPKC~I and ~II, which display 100% identity over 
their first 621 amino acids but then diverge in the last 50-51 carboxy terminal residues (ana 
et a1., 1986a). Importantly, these divergences are conserved across rat, rabbit, and human 
suggesting that there are distinct functions encoded by both gene products. To that end, 
Blobe et a1. identified residues in the carboxy terminus of cPKC~II that are hOfll010gous to 
actin binding proteins (Blobe et aI., 1996b). They demonstrated that with long term 
stimulation with phorbol esters, cPKC~II differentially interacts with the actin cytoskeleton 
where it becomes activated, and is then protected from PMA-induced down-regulation. 
In another line of investigation, we have recently reported that prolonged activation of 
PKC with DAG-mimicking phorbol- and non-phorbol PKC agonists can induce the formation 
of a specialized pericentriolar recycling compartment that serves as a novel target for the 
isoenzyme-specific translocation of cPKCa and ~II isoforms, and which we have nanled 
the pericentriol1. Analysis has revealed that cPKC translocation to the pericentrion was 
coincident with an enrichment of the compartment with some plasIlla membrane proteins 
and lipids, including caveolin-1 and ganglioside-GM 1. Kinetic studies with a fluorescent-
conjugated transferrin ligand as a marker of membrane trafficking demonstrated that the 
cPKC-dependent pericentrion functions to sequester membrane recycling components. 
In this study, we investigated the isoenzyme specificity of this novel translocation and 
found that while cPKCa and ~II translocated to the pericentrion, cPKCBI did not. Further 
analysis showed that cPKCBII translocated to the pericentrion in a time- and microtubule-
dependent manner, first accumulating at the plasma membrane within 5 min of stilllulation, 
and then at the pericentrion within 30-40 nlin. The specificity for cPKCBII versus BI and 
the requirement for kinase activity raised the possibility that PC-PLD may be involved in 
the process, and further experiments did indeed implicate PLD in the translocation of cPKC~II 
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to the pericentrion. These results define a novel pathway of translocation of cPKC~II 
requiring differential activation of PLC. These data suggest that cPKC~II differentially 
activates PLD and that this is required for the mechanism of translocation to the pericentrion. 
The implications of these results are discussed. 
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3.2 Materials and Methods 
Materials 
Eagle's minimal essential media, Dulbecco's modified Eagle's medium, and HEPES were 
from Life Technologies, Inc (Gaithersburg, MD). HeLa cells were kindly provided by Dr. 
Dennis Watson (Medical University of South Carolina) and the HEK 293 cell line was 
purchased from American Tissue Culture Collection (Manassa, VA). [~-H] palmitic acid 
was from New England Nuclear Life Sciences Products (Boston, MA). 4f3-phorbol-12-
myristate-13-acetate (PMA) was purchased from Calbiochem (La 10lla, CA.). Mouse 
monoclonal anti-HA antibody was from Covance (Oakland, CA). Phospholipid standards 
were from Avanti Polar Lipids, Inc (Alabaster, AL). Anti-mouse TRITC secondary antibodies 
were from Molecular Probes, Inc (Eugene, OR.). Whatman silica gel 60 TLC plates were 
from Fisher Scientific (Pittsburgh, PA). All other chemicals were from Sigma (St. Louis, 
MO). 
Cell Culture 
HeLa cells were maintained in Dulbecco's modified Eagle's medium (DMEM) and HEK 
293 ceIJs were maintained in Eagle's Minimal Essential Media (MEM) supplenlented with 
100/0 (v/v) fetal bovine serum, 100 U/ml penicillin, and I 00 ~g/ml streptomycin in a 5% 




All recombinant DNA procedures were carried out following standard protocols. The wild 
type pBK-CMV-GFP-cPKC-f3I1 and kinase-defective pBK-CMV-GFP-K371 R-f311 cPKC 
constructs were previously described (Feng et aI., 1998). PDGF-f3 receptor was amplified 
from a human fetal kidney cDNA library with PCR primers containing a 5' ECD RI and 
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3'XbaJ restriction sites. Amplified PDGF-~-R was ligated into pcDNA3.1-FLAG. HA-
tagged KR-hPLDl was kindly supplied by Dr. Michael Frohman (SUNY-Stony Brook). 
All DNA sequencing was performed at the MUSe DNA Sequencing Facility. 
Indirect Immunofluorescence 
HEK 293 cells were plated onto MatTek (Ashland, MA) confocal dishes at a density of 2.5-
5.0 x 10-5 cells/dish and 24-48 hours later were co-transfected with either HA-tagged KR-
PLD 1 or GFP-cPKC f3II or HA-tagged KR-PLD 1 and GFP-cPKC ~II using Lipofectamine® 
2000 according to manufacturer's recommendations. Twelve hours post transfection, cells 
were either treated with DMSO (0.01 %) or 100 nM PMA for 1 hour and fixed with 3.70/0 
paraformaldehdye/l00/0 methanol for 10 minutes at room temperature. Following fixation, 
cells were permeabilized at -20°C with 1000/c methanol for 5 min. Cells were then washed 
with 1.50/0FBS/PBS 3 times for 5 min each and then blocked with 2.50/0FBS/PBS for 1 hour. 
Primary antibodies were incubated at a dilution of 1 :50 or 1: 100 in 1.5% FBS/PBS with 
0.150/0 saponin for 2 hours at room temperature or overnight at 4°C. Following incubation 
with primary antibody, cells were washed 3 times for 5 min each with 1.5% FBS/PBS. 
TRITC-conjugated secondary antibody (Molecular Probes) was incubated at a dilution of 
1 :50 or 1: 100 in 1.50/0 FBSIPBS and 0.15% saponin for 1 hour. Cells were washed a final 3 
times for 5 min each with 1.50/0 FBS/PBS and visualized immediately with confocal 
mIcroscopy. 
Confocal Microscopy 
Preparation of samples for immunofluorescence is described above. Cells expressing green 
fluorescent (GFP)-fusion proteins alone were viewed live in 10 mM HEPES-buffered media 
or viewed immediately following 10 min fixation with 3.7% paraformaldehyde/lO% 
methanol pre-warmed to 37°e. All confocal images were taken with an Olympus Ultra View 
Spinning Disk Confocal IX-70 system with an Olympus 60X 1.4 NA lens and Kryptonl 
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Argon laser line. Each microscopic image is representative of 20 fields over a minimum of 
three experiments and all images are taken at the equatorial plane of the cell. GFP fusion 
proteins were excited at 488 nm and TRITC was excited at 543. All fluorescent images 
were captured sequentially and combined within the Ultra View software (Perkin-Elmer). 
Raw data images were cropped in Adobe Photoshop® 5.0 for publication. 
Transphosphatidylation assay 
The cellular activity of PLD was assessed with a transphosphatidylation assay modified 
from Yeo et al (Yeo and Exton, 1995). Twelve hours post transfection, HEK 293 cells were 
labeled overnight (12-16 hours) in 35 mm dishes with 3.0 ~Ci/ml p-H]-palmitic acid in 
MEM supplemented with 100/0 FBS and 0.1 % delipidated bovine serum albun1in (BSA). 
Cells were then washed 3 times with PBS and SerUlTI-free MEM/O.l % BSA media was 
added. Cells were allowed to recover in serum free media at 37°C for 30 mins prior to 
stimulation. Ten minutes prior to stimulation, 0.4% I-butanol was added to the cells. Cells 
were stimulated with 100 nM PMA for the specified times and at the noted concentrations. 
All incubations were performed at 37°C. Following stimulation, the culture media were 
removed, and the cells were washed rapidly 3 times with 1 ml ice-cold PBS. Total cellular 
membranes were extracted via the method of Bligh and Dyer (Bligh and Dyer, 1959). Lipids 
were dried down and resuspended in 75 !-AI chloroform:methanol (2: 1). 50 !-AI of the 75 !-AI 
volume was loaded per lane. The thin layer chron1atography (TLC) solvent system consisted 
of ethyl acetate:iso-octane:acetic acid (9:5:2). A phosphatidylbutanol (Ptd-But) standard 
(Avanti) was included in parallel to confirm lipid species. The plate was sprayed with 
EN3HANCE Spray Perkin-Elmer (Boston, MA.) to amplify the tritium signal and exposed 
for autoradiography for 24 hours. The Ptd-But band and the total remaining lipids were 
scraped and separately counted. The [3H]-Ptd-But band was compared to total labeled 




3.3.1 Isoenzyme-specific translocation of cPKCPII to the pericentrion 
To investigate the isoenzyme spe'cificity of cPKCP translocation to the pericentrion, cells 
were transiently transfected with a GFP-tagged-cPKC PI or GFP-cPKC pII and stimulated 
with PMA. Indirect immunofluorescence and confocal microscopic imaging revealed that 
in the absence of phorbol ester stimulation both GFP-tagged cPKC isoenzymes displayed a 
diffuse cytoplasmic localization with exclusion from the nucleus (Fig. 3.1A and B). Addition 
of 100 nM PMA for 1 hour induced translocation of GFP-cPKC PII to both the plasma 
membrane and to a juxtanuclear location (Fig. 3.1 A, panel 2) that colocalized with the 
GM 1 binding, Alexa Fluor-cholera toxin. (AF-CTx-B) (data not shown). In previous studies, 
we demonstrated that translocation of cPKCa and PII coincided with an enrichment of the 
pericentrion in components of lipid rafts including caveolin-I and the ganglioside GM 1 , 
and that the GM I-binding AF-CTx-B could function as a marker of this compartment. In 
contrast, stimulation of GFP-cPKCPI with 1 hour PMA resulted in the translocation of ~I to 
the plasma membrane only as no translocation to the pericentrion was evident (Fig. 3.1 B, 
panel 2). These results suggest that amino acid residues encoded within the carboxy terminus 
of cPKCPI and (311 determine the specificity for translocation of cPKC PII to the pericentrion. 
In order to control for the possibility that there may be different rates of translocation for 
the two cPKC isoenzymes, a time course experiment was performed. Translocation of both 
the cPKCPI and (311 isoenzymes was evident at the plasma membrane within 5 n1in of PMA 
stimulation, suggesting that translocation to the plasma membrane occurs independent of 
carboxy terminus differences (Fig. 3.1 C, panel 1). Beginning at 30-40 min of PMA 
stimulation, cPKCPII appeared at the pericentrion and displayed maximum translocation 
by 60 min (Fig. 3.1 C, panels 3 and 4). On the other hand, the cPKC(3I enzyme remained at 
the plasma membrane at all time points examined out to 3 hours (data not shown). These 
results confirmed that the differences in translocation observed for cPKCPI and (311 were 
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not due to different rates of translocation. Of note, during the time course of cPKC(3I1 
translocation, filamentous structures appeared in a time dependent manner. Preincubation 
with nocodazole, a microtubule depolymerizing agent (Cole and Lippincott-Schwartz, 1995) 
had no effect on the translocation of cPKC (311 to the plasma membrane but nearly totally 
blocked translocation to the pericentrion (Fig. 3.1 C, panel 5). Thus, cPKC~II translocation 
to the pericentrion occurs in a time-dependent manner and appears to require microtubules. 
3.3.2 Kinase activity is required for translocation of cPKC PII to the pericentrion. 
To investigate the role of kinase activity in the translocation of cPKC BII to the pericentrion, 
cPKC (311 was stimulated in a prolonged manner with PMA, with or without a 30 minute 
pre-incubation with 3 ~M Go 6976, a specific inhibitor of the calcium-dependent PKC 
isoenzymes (Martiny-Baron et a1., 1993). As seen in Figure 3.2A, when the kinase activity 
of cPKCBIl was inhibited with Go 6976, cPKC(31I translocated to the plasma membrane 
but there was no translocation to the pericentrion. This requirelnent for kinase activity was 
further probed using a kinase-defective GFP-tagged cPKC 1311 mutant K371 R which is 
unable to bind ATP and phosphorylate cPKC substrates. When stimulated with PMA, GFP-
K371 R-f311 was observed to translocate to the plasma membrane, but no pericentrion 
accumulation was evident (Fig. 3.2B). These data suggest that cPKC f3I1 translocation to 
the plasma membrane occurs independent of kinase activity but that kinase activity is required 
for translocation to the pericentrion. 
3.3.3 PC-PLD is activated in a time- and PKC-dependent manner during the prolonged 
stimulation of PKC with phorbol esters 
PC-PLD 1 is a major downstrealn target for calcium dependent, DAG/PMA-sensitive cPKC 
isoenzymes. Currently there are some data regarding isoenzymes-specific differences in 
the cPKC regulation of PLD, including differences between the two PKC(31 and cPKC(3I1. 
In addition, very recently Exton and coJleagues reported that the full length rat cPKCa 
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isoenzyme binds and activates PC-PLD 1 dependent upon the presence of a phenylalanine 
reside (phe 663) in the V5 region of cPKCa (Hu and Exton, 2003). These data implicate a 
possible role for the V5 variable region in the PKC-PLD interaction. These observations, 
coupled with the requirement for kinase activity for cPKC(3II translocation to the pericentrion, 
suggested the hypothesis that the mechanism of this translocation may involve the activation 
of PLD 1. To begin to explore this possibility, it was important to first establish whether 
PLD was activated in this system. Using a transphosphatidylation assay with butanol to 
evaluate cellular PLD activity, HEK 293 cells were treated with 100 nM PMA. As seen in 
Figure 3.3A, Ptd-butanol accumulation, corresponding with PLD activity, was evident 
starting at 30-40 mins of PMA stimulation and this could be completely blocked with 
preincubation with 3 ~M Go 6976 compound. Interestingly, this time frame ofPLD activation 
correlated closely with the translocation of cPKC(3I1 to the pericentrion. 
To detennine if cPKC~I and f3I1 regulated PLD differentially, cells were transiently 
transfected with each PKC isoenzyme and the transphosphatidylation reaction was repeated. 
The efficiency of transfection was similar for both isoenzymes and ranged between 40-50% 
of total cell population. Interestingly, in cells that were transfected with cPKC(3I1 there was 
a higher basal level of PLD activity in the absence of phorbol stimulation when compared 
to cPKCf3l. Upon stimulation with PMA, cells that expressed cPKC{3I1 demonstrated a 
500/0 increase in Ptd-butanol accumulation above cells transfected with cPKC f31 (Fig. 3.3B). 
These data suggest the possibility that the isoenzyme specificity in translocation of cPKC f3 
isoenzymes to the pericentrion may be due to the differential activation of PLD. 
3.3.4 Translocation of cPKCPII to the pericentrion is dependent upon PLD activity 
To investigate whether PLD activity is required for translocation of PKC to the pericentrion, 
I-butanol was utilized as an inhibitor of PLD activity in these cells. HEK 293 cells were 
preincubated with 0.40/0 I-butanol for 10 min prior to long term PMA stimulation. Pre-
incubation with I-butanol had no effect on the translocation of cPKC(3I1 to the plasma 
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membrane, but there was a cOlnplete inhibition in the translocation of cPKC to the pericentrion 
(Fig. 3.4A, panels 1-2). This inhibition was specific for the primary alcohol since the 
secondary alcohol 2-butanol did not block translocation (data not shown). To confirm this 
pharmacological inhibition, a catalytically deficient mutant PLD, KR-PLD I, was 
cotransfected along with GFP-cPKCBII into HEK 293 cells and trafficking of cPKCBII to 
the pericentrion was evaluated. When GFP-cPKCBII was stimulated in a prolonged manner 
with PMA, the co-expression of KR-PLD 1 had no effect on the translocation cPKCBII to 
the plasma nlembrane but there was a total block of translocation to the pericentrion (Fig. 
3.4A, panel 3). The ability of the KR-PLDI mutant to inhibit PLD was evaluated in 
transphosphatidylation assays that was performed in parallel with the confocal studies. 
Transient transfection of KR-PLD 1 reduced endogenous PLD activity by approximately 
500/0 (Fig. 3.4B), thus. confirming that the KR-PLD 1 inhibited cellular PLD activity. These 
data demonstrate that PLD activity is involved in the translocation of cPKC to the pericentrion. 
3.3.5 Physiological elevation of DAG derived from the activation of the PDGF-fl 
receptor induces the translocation of cPKCf}II to the pericentrion 
Stimulation of some cells with angiotensin, bombesin, PDGF, or vasopressin results in a 
biphasic elevation of DAG with an initial peak at ]-2 minutes generated by hydrolysis of PI 
lipids and a second more sustained peak that derives from the hydrolysis of PC by PC-PLD. 
Since cPKC translocation to the pericentrion requires a long term exposure to phorbol esters, 
it was hypothesized that an agonist that activates PC-PLD and generates a sustained DAG 
Inay be sufficient to induce translocation of PKC to the pericentrion. GFP-cPKCBII was 
transiently transfected into HEK 293 cells that stably expressed a FLAG-tagged PDGF-B 
receptor in HEK 293. In the absence of expressed receptor, cPKC~II was observed in a 
diffuse cytoplasmic location with no increase at the juxtanuclear location (Fig. 3.5A, panel 
1). In contrast, cells expressing the receptor and cultured in the presence of serum displayed 
an increase in cPKC concentration at the plasma membrane but more significantly at the 
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juxtanuclear location (Fig. 3.SA, panel 2). The juxtanuclear accumulation of cPKC~II was 
observed in approximately 30% of transfected cells cultured in the presence of serum (Fig. 
3.SB). Further, cPKC~II accumulation at the juxtanuclear location was not observed in 
cells that were cultured in serum-free nledia and this could be restored with the addition of 
50 ng/ml POOF BB (Fig. 3.5A, panels 3 and 4). This translocation of cPKC~II to the 
plasma membrane and juxtanuclear location correlated with the serum- and PDGF-BB 
agonist-induced accumulation of Ptd-butanol (Fig. 3.Se). To investigate the role of the PC-
PLO-derived DAG, cells were incubated with propranolol, an inhibitor of lipid phosphate 
phosphatase. luxtanuclear localization induced with POGF and serum was lost in the 
presence of propranolol suggesting that it was the OAG from PLD that was important (data 
not shown). These data suggest that under conditions where PC-PLD is activated and DAG 
is elevated for prolonged periods of time, cPKC~II transJocates to the pericentrion. 
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3.4 Discussion 
In the preset study, we have identified a role for the carboxy terminal V5 variable region in 
the differential subcellular localization of cPKC(3 isoenzymes to the pericentrion following 
sustained activation with OAG-inducing POGF and OAG-mimicking phorbol esters. 
Investigation into the mechanism, revealed that cPKCf3I1 translocation occurred in a time-
and activity-dependent manner, and was due to the differential activation of PLD. These 
data define an isoenzyme-specific function for cPKC in the regulation of PLD, and in turn, 
the reciprocal regulation of PKC through the modulation of PKC subcellular localization. 
Additionally, we also provided evidence for the translocation of cPKCf3I1 that was stimulated 
through a sustained elevation ofDAG generated by PC-PLO coupled to the PDGF-B receptor. 
These data suggest that cPKC translocates to this novel conlpartment under physiological 
conditions. 
Isoenzyme-specific differences in the subcellular localization and function of cPKCBI 
and ~II have been previously reported. Using indirect immunofluorescence and monoclonal 
antibodies, several groups have observed an isoenzyme-specific association of cPKCBII 
with the actin cytoskeleton (Disatnik et aI., 1994; Goodnight et aI., 1995). To that end, 
Blobe and co-workers identified an actin-binding sequence (ABS- J) located within the V5 
region of cPKC(3I1 that was absent from cPKCBI (Blobe et aI., 1996a). This sequence was 
found to be necessary for the phorbol ester-induced translocation of cPKC(311 to the actin 
cytoskeleton and isoenzyme-specific functions associated with this translocation including 
protection from down regulation. Further, Yamamoto et a1. identified specific and opposing 
functional roles for the cPKC(3 isoenzymes in vascular smooth muscle cells (Yanlamoto et 
aI., 1998). They reported that upon overexpression of cPKC(31 there was a stimulation of 
celJ proliferation whereas cPKC(3II overexpression was inhibitory to cell proliferation. In 
addition to these studies, there are also a nunlber of other studies that have proposed specific 
subceHular localization and/or functions for either one or the other isoenzyme but in most 
cases there was no direct comparison between J3I and (311 and it is not known if the proposed 
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function was isoenzyme-specific (Hocevar and Fields, 1991). 
PC-PLD is a nlajor downstream target for PKC. Data from overexpression studies and 
in vitro experiments with purified or reconlbinant protein indicate that it is the calcium-
dependent cPKC isoenzymes (a and (3) that are the primary PKC regulators of PLD in the 
cell. Additionally, there are some data to suggest possible isoenzyme-specific differences 
between cPKCf31 and (3II. For instance, a role for cPKC(31 has been suggested through the 
examination of PLD activity in cells that stably overexpressed cPKC(31 and which displayed 
an enhanced formation of DAG in response to phorbol ester treatnlent (Pachter et aI., 1992; 
Pai et aI., 1991). These results were further supported with studies that used purified PKC 
and a cell-free system to demonstrate a rank order of potency for PLD activation with cPKC 
f3I>a>y and (311 showing little or no activity (Lopez et aI., 1995). Interestingly, these studies 
are in conflict with the current study as well as a nUlllber of in vitro studies that have seen 
little to no differences in the specificity of (31 and BII activation of PLD. However, a very 
recent report by Exton and colleagues who identified residues in carboxy terminus of cPKCu 
as critical to the activation of PLD by PKC underscores the importance of the variable 
region in PKC-PLD relationship. 
Of note, while researching the literature for this manuscript it was discovered that there 
is an inconsistency in the nomenclature that has been applied to the cPKC(3 isoenzymes 
very early on. Whereas Nishizuka and co-workers (Ono et aI., 1987) proposed to name the 
673 amino acid splice product, cPKC(3II, and the 670 amino acid protein (31, Coussens et aI. 
(Coussens et aI., 1987) used the opposite terminology. Currently, the accepted nomenclature 
is that the longer gene product is cPKC(311 and the shorter one, cPKC(3I. 
The major findings of this study have important implications for cell signaling through 
PDGF and other agonists that couple to PC hydrolysis and induce a sustained elevation of 
DAG. Currently, there are conflicting data regarding the function of the sustained DAG 
generated by PDGF stimulation and whether it can activate PKC in a lnanner analogous to 
DAG derived from PI lipid hydrolysis (Ha and Exton, 1993; Pettitt et aI., 1997). To date, 
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most cell studies that have investigated this issue have failed to detect a translocation event 
(i.e. activation) ofPKC to a particulate/membrane fraction in response to agonist stimulation 
and sustained DAG. In contrast, Ha et al have reported a persistent translocation of nPKC 
epsilon to a membrane fraction in cells stimulated with PDGF (Ha and Exton, 1993). The 
data reported in the present study have demonstrated that stimulation of the PDGF receptor 
and activation of PC-PLD can lead to an alteration in the subcellular localization of PKC 
isoenzymes which is mimicked with phorbol esters. 
In addition, these results impact on the long term use (30-60 min) of phorbol esters to 
probe the cellular functions of PKC. The time course of translocation in this study suggests 
that during phorbol ester stimulation there are isoenzyme-specific differences in subcellular 
localization of cPKC(3I and (311, depending upon length of exposure to PMA. Whereas at 
short time exposure such as 5 min both isoenzymes will be localized to the plasma lnenlbrane, 
starting at 30 min and longer (311 will be found specifica]]y at the pericentrion whereas (31 is 
localized to the plasma membrane. This differential subcellular localization during phorbol 
ester stimulation may lead to disparate isoenzyme effects such as differential down-regulation 
or differential access to compartmentalized substrates. 
Finally, these studies serve to reinforce the continuing application of GFP technology 
and confocal imaging to the study of the PKC. The use of these technologies in the present 
study have allowed the discovery of isoenzyme-specific differences in cPKC subcellular 
localization that other methods (e.g. subcellular fractionation) may not have had the resolution 
to detect. Moreover, these results further illustrate the emerging significance of PKC 





Figure 3.1 Isoenzyme-specific translocation ofGFP-cPKC~II to the pericentrion occurs in a time-
dependent manner and is sensitive to microtubule disrupting agents. A, shown are repre entative 
confocal images of cells transiently transfected with GFP-cPKC~n and treated 12 hours post transfec-
tionwith either 0.01 % DMSO or 100 nM PMA for 1 hour. B, confocal images of cells transiently 
transfected with GFP-cPKC~I and treated with either 0.01 % DMSO or 100 nM PMA for 1 hour. C, 
time course of cells transiently transfected with GFP-cPKC~n stimulation with PMA for the indicated 
time periods. Panel 5 was preincubated with 5 JlM nocodazole followed by 100 nM PMA. Each panel 
is representative of at least 20 60X fields and each micrograph is a single image captured at the equato-




Figure 3.2 Translocation of GFP-cPKCPII requires kinase activity. A, representative 
confocal images of cells transiently transfected with GFP-cPKCpn and treated 12 hour 
post transfection with either 1 hour 100 nM PMA or 30 min preincubation with 3 f.1M Go 
6976 followed by 1 hour 100 nM PMA. B, confocal images of cells transiently tran -
feeted with GFP-K371R-cPKCpn and treated 12 hours posttransfection with either 0.01 % 
DMSO control vehicle or 1 hour PMA. Each panel is representative of at least 20 60X 
fields and each micrograph is a single image captured at the equatorial plane of the nucleu . 
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Figure 3.3 Time course ofPLD activation and differential activation by cPKC~II versus cPKC~I. 
A, cells were steady state labeled overnight and subjected to a transphosphatidylation assay with 100 
nM PMA for the indicated time periods. Represented in the last lane of the autoradiography i the 
effect 3 ~M Go 6976 on the PMA induced accumulation of Ptd-butanol. B, Representative autorad-
iography and quantitation of [3-H]-Ptd-butanol formation. Cells were transiently transfected with 
either cPKCpn or cPKCPI and steady state labeled with [3-H] palmitate overnight. Cell were wa hed 
and treated with either 0.01 % DMSO control vehicle or 100 nM PMA for one hour. Lipids were 
extracted as described in 'Material and Methods' and then separated by thin layer chromatography 
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Figure 3.4 Translocation ofGFP-cPKC beta2 requires PLD activity. A, representative confo-
cal images of cells transiently transfected with either GFP-cPKCbeta2 (panels 1 and 2) or KR-
PLD 1 and GFP-cPKC beta2 (panel 3). Each panel is representative of at least 20 60X field , and 
each micrograph is a single image captured at the equatorial plane of the nucleus. B, the effects of 
KR-PLD1 on endogenous PLD activity. Cells were transiently transfected with either pGC -vec-
tor or KR-PLD1 and 12 hours post transfection subjected to steady state labeled with 3 uCi [3-H] 
palmitate overnight. Cells were washed and then treated with 100 nM PMA for 1 hour. Ptd-butanol 
formation was quantitated by scrapping and scintillation counting. This experiment is repre enta-
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Figure 3.5 Effects of growth factor-induced activation of PLD on cPKC beta2 subcellular 
localization. A, representative confocal images of cells expressing GFP-cPKCbeta2 alone (panel 
1) or stably expressing FLAG-PDGF-beta receptor with transiently transfected GFP-cPKCbeta2 
(panels 2-4). Cells in panels 1 and 2 are cultured in the presence of 10% serum panel 3 is serum 
starved for 3 hours and then stimulated with 50 ng/ml PDGF-BB for 1 hour, and panel 4 was 
cultured in the absence of serum for 3 hours. Each panel is representative of at least 20 60X fields 
and each micrograph is a single image captured at the equatorial plane of the nucleus. B, quantitation 
of the number of cells demonstrating juxtanuclear translocation as a percentage of total transfected 
cells. 20 60X high power fields were examined over 3 separate experiments. C, autoradiography 
of [3-HJ Ptd-butanol formation in cells shown in A. Cells were transfected and maintained in 
media as described above and then subjected to steady state labeling with palmitate for overnight. 
Cells were washed and total lipids extracted as described in 'Materials and Methods' and separate 
with TLC. 
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Members of the protein kinase C (PKC) superfamily mediate a multitude of signaling events 
initiated by the formation of the lipid second messenger, sn-l,2-diacylglycerol (DAG). 
During acute signal transduction, agonist binding to a cell surface receptor leads to the 
phospholipase C-mediated hydrolysis of phosphoinositide (PI) with a subsequent elevation 
in DAG/calcium, and the recruitment and activation of PKC at the membrane. In this 
capacity, DAG serves as a link between PKC activity and compartment-restricted substrates. 
Acute activation of cPKC at the membrane is ensured through the rapid metabolic clearance 
of the OAG signal which leads to the removal of the activating signal and a reversal of 
membrane translocation within 1-2 min (Nishizuka and Nakamura, 1995). 
In contrast to this acute signaling model, DAG can also be generated in a more prolonged 
manner, and this persistent OAG has been proposed to mediate several long term PKC 
functions including cell proliferation and differentiation (Nishizuka, 1986~ Nishizuka, 1995). 
The prinlary physiological source of sustained DAG is derived from the hydrolysis of 
phosphatidylcholine (PC) by PC-specific phospholipase D (PC-PLO). Additionally, OAG 
and PKC activity can be elevated in the cell through a variety of pathological mechanisms 
and sustained PKC activity has been implicated in a number of diseases states (Fleischman 
et aI., 1986; Koya and King, 1998~ Milano et aI., 1994; Preiss et aI., J 986; Wolfman and 
Macara, 1987). In most cases the subcellular target and function of PKC during long term 
activation is unknown. 
We recently reported that the sustained activation of PKC with PC-derived DAG and 
DAG-minlicking phorbol esters can lead to the formation of a lipid raft-enriched juxtanuclear 
compartment that serves as a novel target for cPKC translocation. We further demonstrated 
that PKC translocation to this compartment was coincident with the dysregulation of 
membrane recycling and this was found to be due to the cPKC-dependent sequestration of 
recycling components within the juxtanuclear compartment. These data serve to define a 
novel site of translocation and function for cPKCs during sustained activity. 
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Glucose homeostasis is maintained through a coordination of a specialized network of 
organs/tissues and endocrine hormones that function to preserve a careful balance between 
glucose utilization and glucose production. A primary metabolic defect associated with 
type II diabetes is the inability of the peripheral tissues such as muscle and adipose tissue to 
respond to insulin (insulin resistance) and reduce blood glucose levels (Sheetz and King, 
2002). Under normal circunlstances, binding of insulin to a cell surface insulin receptor 
triggers an intracellular response that induces a redistribution of the major insulin-regulatable 
glucose transporter, GLUT4, from ajuxtanuclear location to the plasma membrane where it 
can then facilitate the transport of glucose across the membrane bilayer. It has been proposed 
that a lesion anywhere along this pathway, including a reduction or block in translocation of 
GLUT4 may lead to insulin resistance (Pessin and Saltiel, 2000). 
Chronic, uncontrolled hyperglycenlia has been linked to the microvascular pathological 
complications associated with type I and type II diabetes (Sheetz and King, 2002). Presently, 
significant evidence has emerged to suggest that chronic hyperglycemia mediates at least 
some of its effects through a persistent elevation ofDAG and the activation ofDAG-sensitive 
PKC isoenzymes (Koya and King, 1998). Indeed, cPKCs have been demonstrated through 
a variety of studies including inhibitor studies and knockout mice to be necessary for many 
of the vascular dysfunctions associated with retinopathy, nephropathy, neuropathy, and 
microangiopathy (Ishii et aI., 1998; Letiges et aI., 2002; Standaert et aI., 1999). Further, 
there are clinical trials currently underway to assess the efficacy of a cPKCf) specific inhibitor 
in the prevention of microangiopathies of diabetes. 
In the present study, we hypothesized that the hyperglycemia-induced elevation of DAG 
and activation of PKC may not be limited to vascular endothelial tissues but that 
hyperglycemia may exert a similar effect on cPKCs in peripheral tissues as well. Given our 
previous data on the functional consequence of sustained PKC activation on membrane 
recycling, it was further hypothesized that hyperglycemia through DAG-PKC may function 
to sequester GLUT4 in a cPKC-dependent compartment and that this may lead to a block in 
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insulin-induced GLUT4 translocation to the membrane. 
We now report that hyperglycemia can induced an elevation of DAG in HEK 293 cells 
and that the hyperglycemia-induced elevation of DAG is sufficient to induce a redistribution 
of cPKC fron1 a diffuse cytoplasmic location to a juxtanuclear compartment. Further, 
hyperglycemia induced a sequestration of GLUT4 in a juxtanuclear compartment of HEK 
293 cells and this occurred in a cPKC-dependent manner. In 3T3 L 1 adipocytes, cPKC 
colocalizes with GLUT4 and this is also in a kinase activity-dependent manner, suggesting 
the intriguing hypothesis that sustained PKC activation may have a role in postreceptor 
insulin resistance. 
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4.2 Materials and Methods 
Materials 
Eagle's minimal essential media (MEM), Dulbecco~s modified Eagle's medium (DMEM), 
HEPES, and trypsin-EDTA were fronl Life Technologies, Inc (Gaithersburg, MD). Fetal 
bovine serum (FBS) was from Summit Technology. [y-32P]ATP (10 mCi/nll, 3000Ci/mmol) 
were from NEN Life Science Products (Boston, MA). Murine 3T3 Ll preadipocytes and 
HEK 293 cell lines were purchased from American Tissue Culture Collection (Manassa, 
VA). 413-phorbol-12-myristate-13-acetate (PMA) was purchased from Calbiochem (La Jolla, 
CA.). Anti-FLAG M2 monoclonal antibody was from Sigma (St. Louis, MO). Rabbit 
polyc]onal Anti-GLUT4 was from Abcanl (England, UK). Silica Gel 60 thin-layer 
chronlatography plates were from Whatnlan (Clifton, NJ). Anti-mouse TRITC secondary 
antibodies were from Molecular Probes, Inc (Eugene, OR.). All other chemicals were from 
Sigma (St. Louis, MO). 
Cell Culture 
3T3-L 1 preadipocytes were maintained in DMEM with 25 mM glucose and supplemented 
with 10% (v/v) fetal bovine serum, 100 U/ml penicillin, and 100 ttg/ml streptomycin until 
differentiation. HEK 293 cells were maintained in MEM supplemented with 100/0 (v/v) 
fetal bovine serum, 100 U/m] penicillin, and 1 00 ~g/ml streptomycin in a 5% CO incubator 
2 
at 37°C. Cells were passaged every 3-4 days to maintain logarithmic growth. 
Diacylglycerol measurements 
HEK 293 cells were maintained in DMEM containing either 25 mM glucose or 5.5 mM 
glucose for the designated times. At time of harvest, cells were washed twice with 1 ml ice-
cold PBS and lipids were extracted according to the method of Bligh and Dyer (Bligh and 
Dyer, 1959). One ml and 0.3 ml (in duplicates) of chloroform out of the organic phase were 
transferred into separate aliquots, dried down, and used for phosphate measurements. DAG 
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levels were measured with the Escherichia coli DAG kinase assay (Preiss et a1., 1986). 
Briefly, the Jipids were incubated at room temperature for 30 min in the presence of (3-
octylglucoside/dioleoyl-phosphatidyl glycerol micelles, 2 mM dithriothreitol, 5 !J,g of proteins 
from the DAG kinase membranes, and 2 mM ATP (mixed with [y_32P]ATP in a final volume 
of 1 OO~.l. After the lipids were extracted by the method of Bligh and Dyer, the reaction 
products were separated by TLC in chloroform:acetone:methanol:acetic acid:H 0 
2 
(50:20: 1.5: 10:5), and the radioactivity associated with phosphatidic acid was measured by 
scrapping and scintillation counting. DAG levels were quantitated by using external standards 
and were normalized to phosphate. 
Adipocyte Differentiation 
3T3-Ll adipocytes were differentiated according to previously published methods. Briefly, 
the adipocyes were plated at a density of 1.0 X 106 in either 10 cm dishes and grown to 
confluence. Three days post confluence, differentiation media consisting of DMEM with 1 00/0 
FBS, 25 n1M glucose, 0.5 mM methylisobutylxanthine, 0.25 ~M dexamethasone, and 5 ~gl 
ml insulin was added to the cells and incubated for 3 days. At the beginning of differentiation 
day 4, media was replaced with DMEM containing 100/0 FBS and 25 InM glucose, and cells 
were grown for 8 to 12 days. Media was replaced every two days. Cells were used directly 
for immunofluorescence or transfected via electroporation. 
Transfection of 3T3-Ll adipocytes 
Fully differentiated 3T3-L I adipocytes were trypsinized and centrifuged at 800xg. The cell 
pellet was washed into 10 ml of ice-cold PBS. The cell pellet was then resuspended into a 
total volume of 500 !AI of PBS and DNA was added to 50 ~g. Cells were incubated for 10 
min on ice prior to electroporation. Cells were electroporated (Gene Pulser) in 0.4 mm 
cuvettes at 0.15 k V and 960 !JFarad. Following e]ectroporation, the adipocytes were rested 
on ice for 10 minutes and then washed once with DMEM containing 10% FBS and plated 
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onto 35 mm confocal dishes (MatTeK). Adipocytes were grown for 24-48 hours and then 
processed for indirect immunofluorescence. 
Indirect Immunofluorescence 
HEK 293 cells were plated onto MatTek (Ashland, MA) confocal dishes at a density of 2.5-
5.0 x 10-5 cells/dish and 24 hours later were co-transfected with FLAG-tagged GLUT4 and 
GFP-cPKCf)II using Lipofectamine® 2000 according to nlanufacturer's recommendations. 
Twelve hours post transfection, cells were treated either with DMSO (0.01 0/0) or 100 nM 
PMA for I hour and fixed with 3.70/0 paraformaldehdye/IO% Dlethanol for 10 lninutes at 
room temperature. Following fixation, cells were permeabilized at _20DC with 100% 
methanol for 5 min. Cells were then washed with 1.5%FBSIPBS three tiDles for 5 min each 
and then blocked with 2.5%FBS/PBS for 1 hour. Primary antibodies were incubated at a 
dilution of 1 :50 or 1: 100 in 1.5% FBS/PBS with 0.150/0 saponin for 2 hours at room 
temperature or overnight at 4 DC. Following incubation with primary antibody, cells were 
washed three times for 5 min each with 1.5% FBS/PBS. TRITe-conjugated secondary 
antibody (Molecular Probes) was incubated at a dilution of ] :50 or I:] 00 in 1.50/0 FBSIPBS 
and 0.] 5% saponin for 1 hour. Cells were washed a final three times for 5 min each with 
1.5% FBS/PBS and visualized immediately with confocal microscopy. 
Confocal Microscopy 
Cells were plated onto MatTek confocal dishes at a density of 2.5-5.0 x 10-5 cells/dish and 
allowed to adhere for 24 hours. Co-transfection of FLAG-tagged GLUT4 and GFP-cPKCa 
using Lipofectamine 2000 was carried out according to the manufacturer's instructions. 
Twelve hours post transfection, ceJ]s were treated either with DMSO (0.01 0/0) or 100 nM 
PMA for 1 hour and fixed with 3.7% paraformaldehdye and 100/0 methanol for 20 minutes 
at room temperature. Preparation of samples for inlillunofluorescence is described above. 
Cells expressing GFP-fusion proteins alone were viewed immediately following fixation. 
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All confocal inlages were taken with an Olynlpus Ultra View Spinning Disk Confocal IX-
70 system with an Olympus 60X 1.4 NA lens and Krypton/Argon laser line. Each image is 
representative of 20 fields over a minimum of three experiments and images represent the 
equatorial plane of the cell. Green fluorescent protein (GFP) fusion proteins were excited 
at 488 nm and TRITC was excited at 543. All fluorescent images were captured sequentially 
and combined within the UltraView software (Perkin-Elmer). 
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4.3 Results 
4.3.1 Hyperglycemia induces an elevation of DAG in HEK 293 cell 
To investigate if chronic exposure to hyperglycemia can induce an elevation of DAG in a 
fibroblastic cell model, HEK 293 cells were incubated in the presence of 100/0 FBS-DMEM 
containing either 5.5 mM or 25 mM D-glucose for three weeks. A three weeks exposure 
was chosen in order to mimic chronic exposure to hyperglycemia that is seen in diabetes. 
Total cellular lipids were then extracted via the method of Bligh and Dyer and subject to a 
DAG kinase assay. As seen in figure 4.1 A, there was an approxinlate 750/0 increase in 
cellular levels of DAG when cells were exposed to high glucose for 3 weeks when compared 
to low glucose. These results demonstrate that hyperglycemia can induce an elevation of 
DAG in fibroblasts. 
4.3.2 Hyperglycemia alters the subcellular localization of endogenous cPKCa 
We have previously reported that under conditions of sustained activation, cPKC isoenzymes 
a and J)II translocate to a novel, juxtanuclear compartment that functions in the dysregulation 
of Inembrane trafficking. Given these previous results, and the strong link between 
hyperglycemia and activation of the DAG-PKC pathway, we hypothesized that the 
hyperglycemia-induced elevation of DAG in fibroblasts may also lead to alteration of PKC 
subcellular localization with an accumulation of PKC at the juxtanuclear compartment. To 
investigate this hypothesis, cells were either exposed to 5.5 mM or 25 mM glucose for three 
weeks and then subjected to indirect inlmunofluorescence (IF) and confocal nlicroscopy to 
determine the subcellular localization of endogenous cPKCa. After three weeks exposure 
to low glucose, cPKCa was found in a diffuse cytoplasmic localization in all cells (Fig. 
4.1B, pane] 1). In contrast, following three weeks exposure to hyperglycemic conditions, 
cPKCa was found localized to both a diffuse cytoplasmic and a juxtanuclear location (Fig. 
4.1B, panel 2). These results suggest that hyperglycemia acting through sustained elevation 
of DAG may alter the subcellular localization of cPKCa. 
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4.3.3 Hyperglycemia induces the internalization and sequestration of GLUT4 to a 
juxtanuclear location in HEK 293 cells 
The effects of hyperglycemia on GLUT4 were investigated in the HEK 293 cell model. The 
HEK 293 cell model was utilized initially due to the clear evidence of DAG elevation with 
three weeks hyperglycemia and the alteration of PKC subcellular localization. Since these 
cells do not contain endogenous GLUT4, stable cell lines were generated expressing a FLAG-
tagged GLUT4. Overexpression of a FLAG-tagged GLUT4 protein in the presence of low 
glucose led to a predominant plasma membrane localization of GLUT4 (Fig. 4.2A, panel 
1). Interestingly, the localization of GLUT4 to the plasma membrane is unlike what is 
reported for GLUT4 in 3T3 LI adipocytes and this may be indicative of a lack of molecular 
components required to sequester GLUT4. Conversely, another intriguing possibility is 
that plasma nlembrane localization is the default localization for GLUT4 and that there are 
specific conditions that mediate the sequestration of GLUT4 in experimental models. In 
exploration of these postulations, following 3 weeks of hyperglycemia there was a marked 
increase in GLUT4 found in ajuxtanuclear location (Fig. 4.2B, panel 2). These data suggested 
that hyperglycemia, on its own, may be partially involved in the compartmentalization of 
GLUT4. 
4.3.4 Hyperglycemia induces the sequestration of GLUT4 at a juxtanuclear 
compartment in a cPKC-dependent manner 
Given the ability of hyperglycemia to induce an elevation of DAG and a translocation of 
cPKCa to a similar juxtanuclear compartment, it was hypothesized that the effects of 
hyperglycemia on GLUT4 subcellular localization may be mediated through cPKC. To 
probe this question, cells that had been exposed to 3 weeks of high glucose, which was 
shown to be sufficient to induce translocation of cPKC to a juxtanuclear compartment, were 
incubated for 1 hour in the presence of a 3 !-AM Go 6976, a cPKC-selective kinase inhibitor. 
Incubation with 3 !-lM Go 6976 resulted in a cytoplasmic dispersion of the GLUT4-positive 
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vesicles leading to the loss of concentrated GLUT4 at a juxtanuclear conlpartment when 
compared to vehicle control (Fig. 4.2B and C). These data suggest that hyperglycemia 
sequesters GLUT4 at a juxtanuclear location in HEK 293 cells and that cPKC activity is 
required for this effect. 
4.3.5 cPKCa and GLUT4 colocalize to a juxtanuclear location in HEK 293 cells with 
PMA 
Phorbol esters such as phorbol-12-myristate-13-acetate (PMA) are naturally-occurring tumor 
promoters as well as specific DAG mimetics. To investigate if the hyperglycemia effect on 
GLUT4 was through DAG, ceIls stably expressing FLAG-tagged GLUT4 were transiently 
transfected with GFP-cPKCa and then treated with 100 nM PMA for one hour. In cells 
treated with DMSO vehicle alone, GLUT4 was found predominantly at the plasn1a nlembrane 
and GFP-cPKCa was localized to a diffuse cytoplasmic location (Fig. 4.3A). Treatnlent 
with PMA lead to the internalization of GLUT4, the translocation of GFP-cPKCa, and the 
partial colocalizaton of GLUT4 with GFP-cPKCa in a juxtanuclear location (Fig. 4.3B). 
This PMA induced colocalizaton of GLUT 4 and cPKCa was dependent upon kinase activity 
since incubation with 3 ~M Go 6976 following one hour PMA led to the dispersal ofGLUT4 
and GFP-cPKCa, and the loss of colocalization (data not shown). These data demonstrate 
that the DAG-mimicking phorbol ester, PMA, is able to reproduce the effects of 
hyperglycemia on cPKC and GLUT4 localization demonstrating activation of PKC is 
sufficient to sequester GLUT4 intracellularly. 
4.3.6 cPKC localizes to a juxtanuclear compartment in 3T3 Ll adipocytes and 
localization is dependent upon kinase activity 
To begin to investigate whether long term activated cPKCa exerts a direct effect on GLUT4 
trafficking in an adipocyte model, the subcellular location of cPKCa was probed in the 3T3 
L 1 adipocytes in the presence or absence of phorbol esters. 3T3 L 1 adipocytes were 
91 
transiently transfected with a GFP-tagged cPKCa via electroporation and treated with PMA 
to stimulate sustained DAG conditions. In an unstimulated state, (but in the presence of 
high glucose which is required to maintain the differentiated state of 3T3 adipocytes) cPKCa 
was found predominantly in a diffuse cytoplasmic location as well as at a juxtanuclear 
location (Fig. 4.4A, panel 1). Stimulation with PMA for 1 hour led to the translocation of 
GFP-cPKCa to the plasma membrane and a slight enhancement in the cPKC at the 
juxtanuclear location (Fig. 4.4A, panel 2). Incubation with 1 0 ~M of the cPKC-selective 
kinase inhibitor, Go 6976, for 1 hour following one hour of 200 nM PMA resulted in a total 
loss of cPKCu accumulation at the juxtanuclear compartment (Fig. 4.4A, panel 3). These 
results suggest that, similar to HEK 293 fibroblasts, cPKC in 3T3 L 1 adipocytes localizes 
to a juxtanuclear compartment during sustained activation and this occurs in a kinase 
dependent manner. 
4.3.7 cPKCa colocalizes to a subset of GLUT4 positive vesicles in 3T3 Ll adipocytes 
To investigate if cPKC and GLUT4 colocalize in 3T3 Ll adipocytes, transiently transfected 
3T3 adipocytes were incubated in the presence 200 nnl PMA for 1 hour and the subcellular 
localization of GLUT4 was probed with indirect immunofluorescence for endogenous 
GLUT4. As shown in Fig. 4.4B (panels 1-3 and inset), GFP-cPKCa was found to colocalize 
to a subset of GLUT4-positive vesicles at a juxtanuclear location. These results show that 
in a physiologically-relevant model of adipocytes, cPKC and GLUT4 colocalize, and that 
PKC may be involved in this sequestration. 
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4.4 Discussion 
These results demonstrate that chronic exposure (three weeks) to hyperglycemia (25 mM) 
can induce an elevation of DAG as measured by the DAG kinase assay, and that this leads 
to an alteration in the subcellular localization of cPKC and GLUT4 to ajuxtanuclear location 
in HEK 293 cells. These effects of hyperglycemia on GLUT410calization in HEK 293 cells 
were shown to be cPKC dependent and could be fully recapitulated with phorbol esters. 
Further, the activity-dependent colocalization of cPKCa to a subset of GLUT4-positive 
vesicles in 3T3 L I adipocytes suggests that this interaction may occur within a physiological 
context. The adipocyte cell system represents a relevant model to further investigate the 
effects of sustained cPKC activity on GLUT4 recycling. 
The current understanding of the molecular mechanism(s) regulating GLUT4 
conlpartmentalization in 3T3 L 1 adipocytes is incomplete (Bryant et aI., 2002). In the 
absence of insulin, GLUT 4 is found concentrated in a membranous compartment concentrated 
around the trans-Golgi region. It has been proposed that GLUT4 resides in vesicular 
derivatives of the endosomal system and that GLUT4 is maintained in the intracellular 
location through a high rate of endocytosis and relatively low rate of exocytosis. Stimulation 
with insulin triggers a large increase in the exocytic rate and this Jeads to the rapid 
redistribution of GLUT4 to the membrane. Confirmation that GLUT4 may be reside in 
some aspect of the endosomal system arises from biochemical studies that have found 30-
40% of GLUT4 associated with recycling markers such as the transferrin receptor. This 
model; however, is currently in dispute since transferrin recycling is only modestly responsive 
to insulin signaling (Bryant et aI., 2002; Pessin and Saltiel, 2000). 
The direct implication of these studies is that hyperglycemia through DAG can mediate 
a persistent activation of cPKC isoenzymes and that this leads to the dysregulation of 
membrane recycling i.e. sequestration ofGLUT4 at an intracellular location. Overexpression 
of FLAG-tagged GLUT4 in HEK 293 cells which localized to plasma membrane in the 
presence of low glucose allowed the specific determination of the effects of hyperglycemia 
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and the identification of the role of cPKC activity. 
The identification of a novel function for cPKC during sustained activation induced by 
hyperglycemia-derived DAG further illustrates the role of cPKC as a mediator of long term 
cellular functions. As such, it is important to investigate other disease models where there 
is an established or proposed elevation of sustained DAG to evaluate the role of membrane 
recycling dysregulation in the pathological mechanism. Further, these studies serve to 



























glucose conc. (3 week exposure) 
Figure 4.1 Chronic hyperglycemia induces an elevation ofDAG and alteration of cPKC sub-
cellular localization. A, HEK 293 cells were exposed to either 5.5 mM or 25 mM D-glucose for 
three weeks and lipids were extracted via the method of Bligh and Dyer. Total extracted lipids were 
subjected to a DAG kinase assay and separated via TLC. The 32-P-DAG band was scraped and 
counted. DAG levels were normalized to phospholipid phosphate to give DAG pmoles/nomles 
phosphate. B, representative confocal images of cells that were exposed to either 5.5 mM or 25 mM 
D-glucose for three weeks and then processed for immunofluorescence as detailed under "Experi-
mental Procedures". Cells were probed for endogenous cPKCcx. Micrographs are single images 
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Figure 4.2 Hyperglycemia induces a sequestration of GLUT4 to a juxtanuclear compartment in a 
cPKC-dependent manner. A, indirect immunofluorescence and confocal images of HEK 293 cells 
stably expressing FLAG-tagged GLUT4 were maintained in either 5.5 mM or 25 mM D-glucose for 
three weeks and then processed for indirect immunofluorescence as detailed in "Experimental Proce-
dures". B, confocal images of HEK 293 cells stably expressing FLAG-tagged GLUT4 that were cul-
tured in 25 mM glucose DMEM for three weeks and then incubated with either 0.01 % DMSO vehicle 
control or 3 J..lM Go 6976 for one hour. C, quantitation of cells exhibitingjuxtanuclear sequestration of 
FLAG-GLUT4 induced with hyperglycemia and treated with or without Go 6976 for one hour. Cells 
exhibiting uxtanuclear sequestration of GLUT4 were counted in twenty 60X fields over three separate 




Figure 4.3 PMA induces sequestration of FLAG-tagged GLUT4 and GFP-cPKC alpha in 
a juxtanuclear compartment of HEK 293 cells. Confocal images of HEK 293 cells stably 
expressing FLAG-GLUT 4 that were transiently transfected with GFP-cPKC alpha. Cells were 
maintained in 5.5 mM D-glucose at all times. A, cells were treated for one hour with 0.01 % 
DMSO vehicle. B, cells were treated with 100 nM PMA for one hour and processed for indirect 




Figure 4.4 cPKC alpha colocalizes with endogenous GLUT4 in 3T3 Ll adipocytes in 
kinase activity-dependent manner. Representative confocal images of3T3 Ll adipocytes 
48 hours post electroporation with GFP-cPKC alpha. A, GFP-cPKC alpha in 3T3 Ll 
adipocytes treated with 0.01 % DMSO control vehicle (panell), GFP-cPKC alpha express-
ing 3T3 Ll adipocytes treated with 200 oM PMA for one hour (panel 2), 3T3 Ll adipocytes 
expressing GFP-cPKC alpha and treated with 200 nM PMA followed by 10 ~ Go 6976 
(panel 3). B, confocal imaging of 3T3 Ll adipocytes expressing GFP-cPKC alpha and 
treated with 200 oM PMA for one hour. Indirect immunofluorescence was performed for 
endogenous GLUT4. 
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Chapter 5: Concluding Discussions 
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5.1 Summary 
Protein kinase C (PKC) is subject to spatial and temporal regulation through dynamic 
fluctuations in lipid second messengers, especially sn-1 ,2-diacylglycerol (DAG). DAG or 
DAG-mimicking phorbol esters can nlodulate PKC on several levels: 1) the formation of 
DAG in the membrane leads to a direct interaction of DAG with the Cl domain of PKC, 
and the recruitment and anchoring of PKC at the membrane. In the case of the cPKC 
isoenzymes, recruitment/anchoring involves a cooperative effort between the C 1 and the 
calcium-dependent, acidic phospholipid binding C2 domain; 2) DAG binding to the CI 
domain induces maximal activation of PKC in the presence of spatialJy-defined protein 
substrates. In this capacity, DAG functions to tightly couple PKC activation to the vicinity 
of compartment-specific substrates; and 3) nletabolic clearance of DAG signal from the 
plasma membrane leads to the conconlitant loss of the PKC from the membrane. "Reverse 
translocation" or the return of PKC to the cytosol requires kinase activity and 
autophosphorylation of a conserved serine (660) that acts to counter the C2 domain 
interactions at the membrane. Thus, the duration of PKC association with membranes is a 
direct reflection of cellular DAG levels and PKC activity. 
During acute signaling events, DAG levels are elevated in the menlbrane for only a very 
short period of time (1-2 min). As a consequence, PKC translocation and activation at the 
membrane is short-lived, but this is of sufficient tinle to trigger signaling cascades that lead 
to acute cellular responses (e.g. secretion, glycogenolysis, neurotransmitter release). In 
contrast to this classical model of PKC activation, there is also significant evidence that 
DAG levels and PKC activity can be sustained for more prolonged periods. Cell data have 
indicated that sustained PKC activity is necessary for a variety of normal regulatory processes 
including cell differentiation, mitogenesis, and ceJJ motility. In addition, PKC has been 
implicated in several long tenn pathological processes such as cancer (tumorigenesis, cancer 
metastasis, multidrug resistance), diabetes, and cardiovascular disease. 
These observations have led to the proposal that PKC activity can be divided into two 
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general categories: 1) those cellular processes that involve a transient activation of PKC as 
is seen in signal transduction and this is mediated by DAG that is present in the membrane 
for 1-2 minutes. In this acute model of activation, the plasma membrane is considered the 
primary target for PKC~ and 2) cellular functions that involve a persistent elevation of DAG 
and PKC activity (hours-days) (Blobe et aI., 1996b; Nishizuka, 1995). Currently, little is 
known regarding the subcellular localization of PKC during exposure to sustained DAG. 
The central hypothesis of this study was that DAG produced in the cell through either 
normal or pathological mechanisms could lead to an alteration ofPKC subcellular localization 
and function. The experimental questions addressed were: 1) where do cPKC isoenzymes 
locate under conditions of prolonged DAG or phorbol ester exposure~ and 2) what is the 
physiological significance of this localization on cellular functioning. The general 
experimental approach taken was to use confocal microscopy to monitor the subcellular 
localization of GFP-tagged PKC isoenzymes in live cells during sustained activation. It 
was anticipated that this approach would allow the identification of a specific subcellular 
structure(s) that would not be detectable with other methods ego subcellular fractionation. 
Preliminary studies with DAG-mimicking phorbol esters revealed that short-term 
activation induced translocation of GFP-cPKCa to the plasma membrane, but that longer 
exposures led to a localization of cPKCa at a secondary, juxtanuclear compartment. A 
similar time-dependent accumulation was also evident when endogenous cPKCa was 
examined with confocal microscopy. These initial results were interpreted to mean that 
during sustained activation, cPKC may translocate to a juxtanuclear compartment such as 
the Golgi complex and that this translocation event had a direct consequence on Go]gi 
functioning (e.g. protein secretion). 
[Use of phorbol esters. Although phorbol esters have been used for more than two 
decades as DAG-mimetics, there are some data to suggest that phorbol esters may exert 
some cellular effects unrelated to PKC activation. Therefore, to confirm that PMA was 
functioning as a true DAG mimetic and to validate the use of PMA in further studies, the 
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effect of endogenous DAG on PKC subcelJular localization was examined using a PC-
PLD-coupled agonist, in this case platelet-derived growth factor (PDGF). Overexpression 
of a FLAG-tagged PDGF-(3 receptor in HEK 293 cells, cultured in the absence of serum, 
resulted in a diffuse cytosolic localization of GFP-cPKCa with no specific accumulation of 
cPKC at either the plasma membrane or juxtanuclear location. On the other hand, the 
addition of 100/0 serum or PDGF-BB to the media of cells overexpressing the PDGF-(3 
receptor led to the accumulation of cPKC at both the plasma membrane and juxtanuclear 
location. Transphosphatidylation assays performed in parallel with the confocal studies 
confirmed that both serum and PDFF-BB stimulated PLD activity in a time frame that 
correlated with cPKC translocation. In addition, the translocation of cPKC to the juxtanuclear 
compartment was found to be sensitive to the lipid phosphate phosphatase inhibitor, 
propranolol, suggesting that DAG-derived from the actions of PLD was necessary for the 
localization of cPKC (data not shown). These data suggest that under physiological 
conditions, sustained DAG can mediate the localization of cPKC to a juxtanuclear 
compa11ment and that the effects of endogenous DAG are reproduced with PMA]. 
5.1.1 Further characterization of sustained PKC activity and the juxtanuclear 
compartment revealed: 
1) PKC translocation was subfamily- and isoenZYlne-spec(fic. Translocation was observed 
for the cPKCa and (311 isoenzymes but was not evident with nPKCE or aPKC~. Specificity 
for the cPKC subfamily was determined to be due to the presence of the C2 domain. Further, 
examination of cPKC(31 and cPKC(3Il translocation revealed an isoenzyme specificity that 
was dependent upon residues within the V5 domain of cPKC(3II (note: the V5 region of 
cPKCa contains residues with chemical properties most similar to cPKC(3II). These data 
suggest that translocation to the juxtanuclear compartment involves a cooperation of the 
C 1, C2 and the V 5 variable region of the cPKC isoenzymes, a and (311. 
2) Colocalization studies revealed that cPKC does not translocate to the Goigi complex. 
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Confocal studies revealed that there was no overlap with markers of the cis, medial, or trans 
subcompartments of the Golgi and cPKC. In addition, the compartment was resistant to 
dispersal with Golgi disrupting agents such as brefeldin A and nocodazole. 
3) cPKC localizes to a subset of recycling endosomes concentrated around the centrosolne/ 
MTOC. The juxtanuclear compartment was centrally defined by markers of the centrosome/ 
microtubule-organizing complex (e.g. gamma tubulin and pericentrin) and localized to a 
subset of transferrin-positive recycling endosomes defined by the small GTPase rab 11 (for 
discussion see below). 
4) Enrichment with lipid r(~ft components. cPKC translocation to the juxtanuclear 
compartment coincided with an enrichment of the compartment with plasma membrane 
lipid raft components, GM I and caveolin-l. Movement of lipid rafts were detected with 
bodipy-conjugated GM 1, fluorescent cholera toxin, and indirect immunofluorescence for 
caveolin-l. Electron microscopy studies confirmed the formation of a l11embranous 
compartment associated with the appendages of the centrosome and immunogold studies 
localized cPKCa to these membranes. 
5) cPKC activity is required for translocation to the c0111part1nent. Kinase inhibitors and 
kinase-defective mutants of cPKC revealed that cPKC translocates to the plasma membrane 
in the absence of kinase activity but that subsequent translocation to the juxtanuclear 
compartment requires an active enzyme. 
6) Kinase activity is required for the structural maintenance o.f the c0111partment, and 
the association o.f cPKC and lipid raft components yvith the c0111part111ent. Application of 
kinase inhibitors following translocation of cPKC and lipid rafts to the juxtanuclear 
compartment resulted in the dispersal of these components into the cytoplasm. 
7) PLD activity is required for translocation. I-butanol and the expression of a 
catalytically deficient PLD (KR-PLDI) had no effect on translocation to the plasma 
membrane but completely blocked translocation of cPKC to the juxtanuclear compartment. 
8) Isoenzyme-specificity of translocation is determined by differential activation of PLD 
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and involves the carboxy terlninus V5 variable region. Examination of cPKC(31 and f3I1 
revealed that (311 preferentially activates PLD upon long term activation with phorbol esters. 
During this project, it was reported by Exton and colleagues that the interaction of the rat 
cPKCa with PLD was dependent upon the presence of a single residue (phe663) within the 
V5 region. These observations and the present study implicate the V5 region in the PKC-
PLD interaction and provide a basis for the differential activation of PLD by cPKC{3I1 and 
isoenzyme-specific translocation to the juxtanuclear compartment. 
9) Sustained cPKC activation leads to a dysregulatiol1 of nlelnbrane recycling. Sustained 
activation of PKC led to the translocation of cPKCa to a juxtanuclear location and a cPKC-
dependent reorganization of transferrin-positive vesicles to a region concentrated around 
the MTOC. cPKC localized to the subset of reorganized transferrin-positive endosomes. 
Kinetic studies demonstrated a retention or sequestration of markers of membrane recycling 
(transferrin) in the cPKC-dependent compartment. 
10) Sustained elevation ofDAG derivedfroln a chronic exposure to hyperglycelnia resulted 
in an alteration of the subcellular localization of cPKCa to ajuxtanuclear location. As has 
been reported on extensively, we observed a hyperglycemia-induced formation of DAG in 
fibroblasts as measured with DGK. Hyperglycemia was also observed to alter the subcellular 
localization of endogenous cPKCa to a juxtanuclear location. 
11) Hyperglycemia leads to the sequestration o.f GLUT4 in a juxtanuclear compartnzent 
of HEK 293 cells and this occurs in a cPKC-dependent manner. Although GLUT4 is 
sequestered at a juxtanuclear location in insulin-sensitive tissues, overexpression of GL UT 4 
in HEK 293 cells resulted in a plasma membrane localization. Chronic exposure of HEK 
293 cells to hyperglycemic conditions led to the internalization and sequestration ofGLUT4 
to a juxtanuclear compartment and this could be blocked with cPKC-selective kinase 
inhibitors. The plasma membrane localization of GLUT4 in HEK 293 cells allowed the 
determination of the effects of hyperglycemia-DAG on GLUT4 in the absence of other 
variables. 
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12) Colocalization of cPKCa and f311 with a subset of GLUT4 in 3T3 L1 adipocytes 
suggests a possible novel role for cPKC in insulin resistance. Indirect immunofluorescence 
studies revealed that cPKC localizes to a subset of GLUT4 vesicles in a kinase activity-
dependent manner. The colocalizaton of cPKC to a subset of GLUT4 was lost upon the 
addition of kinase inhibitors suggesting that colocalizaton requires an active process. A 
definitive role for cPKC in GLUT4 insulin resistance awaits further investigation. 
5.1.2 The pericentrion 
The rab11 versus cPKC-dependent compartlnent. During sustained activation, cPKC 
translocates to a subset of recycling endosomes concentrated in a pericentriolar region and 
defined by the small GTPase, rab 11. Although rab 11 and cPKC overlap/colocalize, functional 
studies revealed that the cPKC-dependent compartment is distinct from the rab 11 
compartment on several levels (Fig 5.1): 
a) rabll is present at the MTOC/centrosome independent of PKC activation. cPKC 
requires sustained activation to translocate to this site. 
b) rab 11 was present at the MTOC location independent of temperature. cPKC and 
Bodipy-GM II AF-CTx-B required physiological temperature for localization at 
this site. 
c) in the absence of cPKC activation, the rab II-defined compartment is absent of 
components of lipid rafts (GM 1, caveolin-I). Sustained activation of cPKC leads to 
an enrichment of GM 1 and caveolin-l , and the association of these components with 
the cPKC-defined compartment was found to be dependent upon cPKC activity. 
d) The MTOC/centrosome-associated recycling compartment is sensitive to microtubule 
disrupting agents e.g. nocodazole. The cPKC-dependent compartment was observed 
to be resistant to disruption upon nocodazole treatment. This is a critical point as it 
sho\:vs that the cP KC cOlnpart111ent is not dependent on nlicrotubules and thus can not 
be easily identified with the MTOC which is strictly dependent on microtubules. 
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e) Finally, cPKC translocate to the pericentriolar region even in cells that lack rab 11 
(data not shown). Thus, the cPKC-dependent compartment cannot be equated with 
the rab II-defined compartment. 
Overall, these studies show that cPKC translocates to a compartment structurally related to 
the rab 11 subcompartment of recycling endosomes but with significant distinguishing 
features. The cPKC compartment may consist of vesicles and membrane structures that 
translocate (and may associate with) the MTOC, but can be distinguished structurally (by 
EM) and functionally. In order to distinguish the cPKC-compartment from other recycling 
compartments and I propose to name it the pericentrion. 
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5.2 Implications and significance 
5.2.1 Novel site ofPKC translocation. These studies define a novel site of translocation 
for cPKC. Previous studies have localized PKC to the Golgi, cytoskeleton, mitochondria, 
endoplasmic reticulum, nuclear envelope and nucleus but this is the first time that PKC has 
been localized to a subset of recycling endosomes. Moreover, these studies identify a novel 
site of translocation for PKC during long term activation which has not previously been 
described. 
5.2.2 Novel compartment. The cPKC-dependent juxtanuclear compartment appears 
to be a specialized conlponent of recycling endosonles that is strictly PKC and temperature 
dependent. It is also a (novel) site for intracellular translocation of components of membrane 
rafts. 
5.2.3 Novel function. The DAG-PKC relationships is one of the most ubiquitous and 
highly conserved signaling mechanisms in biology_ Not surprisingly PKC activity has been 
linked to a large number of cellular functions. The data described here identifies a novel 
function for cPKC isoenzymes. 
5.2.4 cPKC isoenzyme-specific functions: differential activation of PLD. It has 
been recognized for some time now that cPKC isoenzymes can regulate PLD activity and 
that there is isoenzyme-specific differences between cPKCa and f:)II versus (31. These studies 
provide insight into the cPKC(3 isoenzyme-specific activation of PLD and further implicate 
a critical role for the carboxy terminus of cPKC in the activation of PLD. 
5.2.5 PLD regulation of PKC. Most of the studies that have investigated the role of 
DAG-derived from PC-PLD activity have relied upon either in vitro systems or subcellular 
fractionation for monitoring the translocation of PKC (i.e. activation) to membranes. To 
date, these studies have produced conflicting results. In the present study visualization of 
the subcellular trafficking of GFP-tagged cPKC isoenzymes led to the identification of a 
novel PLD-mediated regulation of PKC through translocation to the pericentrion. 
107 
5.3 Speculations 
5.3.1 Alteration of membrane composition 
The enrichment of an intracellular compartment with lipid and protein components of the 
plasma membrane (which coincides with cPKC translocation to the pericentrion) may lead 
to an imbalance in membrane composition with a variety of potential consequences for the 
cell. 
A) Effect of sequestration of membrane proteins 
TraJl.~ferrin. The sequestration of membrane proteins could have profound effects on 
cellular metabolism. Loss of transferrin-transferrin receptor from the plasma membrane 
may lead to a deficiency in iron uptake into the celJ with direct consequences on iron (Fe)-
requiring enzymatic reactions. Previous studies have shown that loss of Fe uptake can 
dranlaticalJy block cell proliferation (K wok and Richardson, 2002). The sequestration of 
transferrin receptors away from the plaslna membrane at the pericentrion may facilitate the 
entry into senescence which would be required in order for cell differentiation to occur. In 
support of this postulation, the PKC-dependent loss of transferrin receptors from the plasma 
membrane has been identified as a key event in the cellular differentiation of K562 cells 
(Schonhorn et aI., 1995). 
MOl1oarnine transporter. There is a Jarge amount of literature that implicates PKC in the 
internalization and down-regulation of the dopamine transporter (DAT) and other neuronal 
receptors and transporters from the plasma membrane of neuronal cells (Apparsundaram et 
aI., 1998; Corey et aI., 1994; Melikian and Buckley, 1999). It is interesting to speculate if 
under certain neurological conditions there is an elevation of DAG and a sustained activation 
of PKC that could lead to the formation of the pericentrion. PKC could then playa role in 
the pathology of these diseases through the sequestration of DAT (or other transporter/ 
receptors) in the pericentrion. To that end, aberrant phospholipase (e.g. PLC, PLD, PLA
2
) 
activity has been detected in a variety of neurological diseases. 
B) Effects on signal transduction. Signal transduction requires a fine balance between 
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being able to detect and respond to a stimulus and the ability to rapidly extinguish a signal 
in order to avoid becoming overly stimulated. The mechanisms that have evolved to protect 
the celJ against uncontrolled stimulation involves either the direct desensitization of the 
receptor system (e.g. phosphorylation) andlor the removal of the ligand-receptor protein 
fronl the membrane surface (down regulation through endocytosis). Thus, a strong 
interdependent relationship exists between membrane recycling and signal transduction. 
Any dysregulation of the afferent or efferent branches of the membrane recycling pathway 
(Inediated under conditions of sustained activation of cPKC) could have a direct impact on 
cell signaling with the resultant inability of a cell to respond appropriately to a particular 
stinlulus. 
On the other hand, the sequestration of membrane proteins in a specialized recycling 
compartment may act to specifical1y modulate the spatia-temporal properties of an initial 
stimulus. That is, the fonnation of an internal cPKC-dependent membranous compartment 
may facilitate or enhance signaling by providing an alternate platform from which membrane 
signaling can continue. Data in support of this hypothesis comes from studies that have 
shown that some receptors are still active when endocytosed from the plasma membrane, 
and more recently fronl molecular studies with a dominant negative form of dynamin which 
revealed that endocytosis is actually required for the full signaling potential of some receptor 
systems. Of course, this could also lead to a pathological response in that the sequestration 
of stimulated components in the juxtanuclear compartment may help to elude the normal 
cellular processes of down-regulation. 
5.3.2 Role for PKC in cholera toxin pathology/lipid raft reorganization 
To this day, V cholerae still represents a formidable health concern. Cholera toxin, which is 
the enterotoxin of v. cholerae, acts by binding specifically to the ganglioside-GM I in the 
plasma membrane of jejunal epithelial cells and this leads to the internalization of CT and 
the pathological loss of electrolytes and water. Data from the present study suggests that 
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the internal accumulation of cholera toxin involves a cPKC-dependent reorganization of 
lipid rafts to an juxtanuclear location. The development of isoenzyme-specific inhibitors 
could lead to alternative therapy for cholera toxin-induced disease. 
5.3.3 Isoenzyme .. specific down regulation. Historically, phorbol esters have been used in 
the study of cellular PKC in two ways: 1) as a cellular probe in which to dissect signaling 
pathways that involve DAG and PKC; and 2) to promote down regulation of DAG/PMA-
sensitive PKC isoenzymes in an effort to establish or discount PKC-specific functions. The 
phorbol ester-induced down regulation of PKC typically requires micromolar concentrations 
of PMA and more than] 6 hours of exposure. Unfortunately, the down regulatory effects of 
phorbol esters are inconsistent among the DAG/PMA-sensitive PKC isoenzynles and this 
has not been well-appreciated in the literature due to poor controls and over-concluded 
data. 
Data from the work of Blobe et a1. and the present study suggest that long tefIn exposure 
of PKC to PMA may lead to an isoenzyme-specific sequestration of PKC (Blobe et aI., 
1996a). Sequestration could possibly result in a differential susceptibility of PKC to down 
regulatory mechanisms resulting in an imbalance of PKC activity and the predominant 
cellular function of unopposed kinase activity. It is conceivable that a mechanism such as 
this could account for the tumor promoting effects associated with phorbo] esters. 
In support of the hypothesis that sequestration at the pericentrion may lead to differential 
down regulation of PKC, there is evidence that the mechanism of PMA-induced down-
regulation specifically targets PKC isoenzymes associated with the plasma nlembrane. As 
a consequence, any PKC that is sequestered away from the plasma membrane during phorhol 
stimulation may be able to elude significant degradation. Preliminary investigation into 
this hypothesis revealed that at 24 and 48 hours of 100 nM PMA exposure, there appeared 
to be a loss of PKC from the plasma membrane but no apparent loss of PKC from the 
juxtanuclear compartment (data not shown). 
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5.4 :Future Directions 
5.4.1 PKC and Diabetes 
A) cPKC potentiates insulin resistance through GLUT4 sequestration? Examine the 
hypothesis that cPKC translocation to a subset of GLUT4-positive vesicles correlates with 
GLUT4 insensitivity to an insulin-stimulated translocation and glucose uptake. 
B) Localization of PKC in tis.'\'ues from diabetic animal models and diabetic patients. 
Although the 3T3 L 1 adipocyte cell model is a thought to represent a good system in which 
to study insulin regulated glucose uptake, there are limitations and disadvantages to this 
nlodel. In order to extend the observations described herein, the subcellular localization of 
PKC isoenzymes should be examined in vivo. Various tissues of animal models such as 
streptozocin-treated rats should be examined. ]n addition, the human tissues from diabetic 
patients (if attainable) should also be examined for the subcel1ular localization of cPKC in 
a physiological context of hyperglycenlia. 
C) Elucidation of the 111ec!zoni.wn(s) 0.1' hyperglycell1ia-induced DAG forn1ation. It is 
important to elucidate the molecular Inechanisln(s) behind the source of sustained PKC 
activation in diabetes. A therapeutic approach of this type would be even more direct than 
an isoenzyme-specific inhibition of cPKC. 
5.4.2 MolecularlMechanistic issues 
A) Ident(ji'catioll (~lPKC substrates at the pericentrion. A requirement for kinase activity 
for the maintenance of this conlpartment suggests that there is specific target for PKC at the 
pericentrion. This could be explored with immunoprecipitation of cPKC(3II versus cPKC(31 
and differential 2-D gel electrophoresis with band cut-out and mass spectronletry. Much 
care should be exercised in the isolation of pericentrion since it must be done at 37°C. To 
overconle potential proteolysis ofPKC that may arise from performing purification at 37°C, 
cPKC constructs could be generated with a modified hinge region that is insensitive to 
calpain I and II-mediated degradation. 
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B) Role of PLD. The studies described herein have shown that PLD is necessary for 
cPKC translocation to the pericentrion but they did not address the issue of whether PLD is 
sufficient for translocation. Use of the RNA Interference represents one of the n10st direct 
methods to investigate this question. Importantly, a ceJlline should be chosen that has been 
well-characterized for PLD isoenzyme expression and that exhibits pericentrion translocation. 
(e.g. HeLa). 
C) Ident~ficati()l1/developrnel1t oj'pericelztriol1-L\jJecijic inhibitors. The identification of 
pericentrion-specific inhibitors should facilitate the study of PKC functions exclusive to the 
pericentrion con1partn1ent. Possible hints may CaIne fronl the work of Pagano, Maxfield or 
Hoestra who have shown chain length and saturation characteristics of lipid moieties that 
are important for sorting to various recycling con1partnlents. 
5.5 Concluding remarks 
These studies have extended our understanding of PKC biology at the subcellular level and 
have further served to distinguish the functional role of PKC as an acutely activated signaling 
enzyme from the role of PKC as a mediator of sustained DAG signals. 
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Figure 5.1 rabll subcompartment versus cPKC-dependent compartment. In the absence 
of sustained PKC activation, the recycling endosomes (as defmed by steady state labeling with 
fluorescent transferrin) can be found in a diffuse cytoplasmic location with a slight concentra-
tion in the juxtanuclear region. The rab 11 subcompartment of recycling endosomes is located at 
the MTOC/centrosome and this localization is independent of PKC activity but dependent on 
microtubules. At this stage, the predominance of lipid rafts (e.g. GMI, caveolin-l) are located 
at the plasma membrane. A sustained elevation of DAG or exposure to DAG-mimicking 
phorbol esters leads to the translocation of cPKC to the plasma membrane and to a juxtanuclear 
compartment that overlaps the rab II-defmed subcompartment. Coincident with cPKC translo-
cation is a reorganization of recycling endosomes to the pericentriolar region and an enrichment 
of this site with lipid raft components. Unlike rab 11, the association of cPKC and lipid rafts at 
the MTOC/centrosome is dependent upon kinase activity but independent of microtubules. 
Moreover, translocation and formation of this compartment coincides with the 
sequestration/retention of recycling components and this is also activity-dependent. Given the 
distinct properties of the cPKC-dependent from the rab 11 subcompartment, I proposed to name 
the cPKC compartment the pericentrion. 
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